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ABSTRACT 
 
Human papillomavirus (HPV) is the most common cause of sexually transmitted 
diseases. It is the causative agent of cervical cancer, anal, and penile cancers. 
 
 The purpose of the study was to determine the knowledge, attitude and behaviour of 
parents towards HPV and HPV vaccine in preventing cervical cancer in girls aged 9 to 
13 years and HPV vaccine uptake.  
 
The study was conducted in Sefhare village, in the Central District of Botswana. The 
researcher selected a quantitative, descriptive cross-sectional research design and data 
was collected using a questionnaire in face-to-face interviews. The study population 
consisted of parents of adolescent girls of ages 9-13 years living in four wards of 
Sefhare village. Data was analysed using SPSS version 19.  
 
The study found a high level (71.8%) of knowledge about HPV infection, cervical cancer 
and HPV vaccine and a positive attitude (81.5%) and behaviour (62%) towards the HPV 
vaccine. 
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
Human papillomavirus (HPV) is the most common cause of sexually-transmitted 
diseases (STDs) in men and women. It is also the established causative agent of 
cervical cancer, anal and penile cancers as well as genital warts in both men and 
women. Protection against strains of HPV that lead to cervical cancer and cause genital 
warts can be achieved through immunisation with the HPV vaccine. To maximise 
effectiveness, the vaccine needs to be given to girls before they are sexually active. 
Several HPV vaccines have been developed, including Gardasil and Cervarix.  
 
Cervical cancer is a serious health problem that claims the lives of many women and 
remains a grave concern in Botswana and around the world (Ramogola-Masire 
2014:81). In sub-Saharan Africa, cervical cancer ranks as one of the two top causes of 
death in women (Ramogala-Masire 2014:81). It is the second most common cancer 
among women, and the most frequent among women aged between 15 and 44 years. 
Cervical cancer can affect any woman.  Many countries have adopted the prevention 
strategy of the HPV vaccine to vaccinate adolescent girls between 9 and 13 years old.   
 
There is a worldwide high incidence rate of HPV infections and cervical cancer. 
Globally, an estimated 500,000 new cases and 274,000 deaths occur annually (Turiho, 
Okello, Muhwezi, Harvey, Byakika-Kibwika, Meya & Katahoire 2014:45). Over 80% of 
the deaths occur in developing countries, where cervical cancer is the leading cause of 
cancer deaths among adult women (Turiho et al 2014:45; Mouallif, Bowyer, Festali, 
Albert, Filali-Zegzouti, Guenin, Delvenne, Waller & Ennaji 2014:409). In France, an 
estimated 2,800 new cases were diagnosed in 2011, leading to 1,000 deaths 
(Haesebaert, Lutringer-Magnin, Kalecinski, Barone, Jacquard, Regnier, Leocmach, 
Vanhems, Chauvin & Lasset 2012:1034).  
 
In a study in North India, it was found that persistent HPV infection led to invasive 
cervical cancer in 80% of sexually active women (Hussain, Nasare, Kumari, Sharma, 
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Khan, Das & Bharadwaj 2014:1). In Morocco, cervical cancer is a major public problem 
and is ranked second to breast cancer in women in terms of incidence and mortality, 
with approximately 1,979 new cases and 1,152 deaths each year, and an incidence and 
mortality rate of 14.1 and 8.4 per 100,000 (Mouallif et al 2014:409). In South Africa, 
more than 7,700 women are diagnosed with cervical cancer every year, of who more 
than half will ultimately die of the disease (Richter 2015:1). The fight against cervical 
cancer includes early detection and screening. The screening can be done using a Pap 
smear or Visual Inspection using Acetic Acid [VIA] (Raditsebe 2017:2). Women are 
screened for cervical cancer and treated immediately if there is evidence of cancer. 
Prevention of cervical cancer is achieved through HPV vaccine. 
 
Several studies have been conducted on parents’ attitudes and knowledge of HPV and 
the HPV vaccine. In 2015, Milimo, Daka, Sikuyuba, Nyirenda and Ngoma (2015:084-
091) conducted a study in the Chipata, Monze, Lusaka and Namwala districts in Zambia 
among parents/guardians of school-going girls aged 9 to 13. Of the respondents, 64% 
reported that they had heard about HPV; 68.5% had heard about the HPV vaccine; 74% 
knew that girls aged 9 to 13 years should be given the HPV vaccine and that it 
prevented girls from contracting HPV infection. Of the respondents, 66% knew that HPV 
could lead to cervical cancer; 84% agreed that the HPV vaccine was helpful in 
preventing cervical cancer and should be given to girls aged 9 to 13 years, and 83% 
would allow their girls to be vaccinated. Milimo et al (2015) found that the respondents 
had knowledge about HPV and the HPV vaccine and therefore a positive attitude 
towards the vaccine. 
 
In Morocco, Mouallif et al (2014:409-416) examined awareness and vaccine 
acceptability among parents. The aim of the study was to assess awareness of HPV 
and the vaccine, and identify factors associated with acceptability of the vaccine among 
parents. The study found low awareness of HPV and the vaccine and low acceptability 
of the HPV vaccine. Acceptability of the vaccine was influenced by higher education, 
previous awareness, the belief that the vaccine was recommended by the Ministry of 
Health or a doctor, and the cost of the vaccine. The study found a relationship between 
awareness of the HPV vaccine and acceptability, which means that parents need 
information about HPV and the vaccine in order to accept the vaccine. The more 
parents accept the vaccine, the more they will take their daughters for vaccination.  
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In 2012, Thomas, Strickland, DiClemente, Higgins and Haber (2012:358-367) 
conducted a study among rural African American parents in three counties in the United 
States of America (USA). The study examined the parents’ knowledge and decisions 
about HPV vaccination, using the Health Belief Model (HBM) as the theoretical 
foundation. The HBM identifies correlates of health-related behaviour and posits four 
factors to account for the behaviour, namely perceived vulnerability; perceived severity; 
perceived benefits, and perceived barriers. The parents who tended to vaccinate their 
daughters scored lower on perceived vulnerability and higher on perceived barriers. The 
study found that the parents with a high educational level tended to vaccinate their 
daughters. This indicated a relationship between the parents’ level of education and 
their decision to vaccinate their daughters.  
 
In the USA, Griffioen, Glynn, Mullins, Zimet, Rosenthal, Fortenberry and Kahn 
(2012:568) explored the factors influencing mothers’ decisions to vaccinate 11-12 year-
old daughters against HPV. The study found that the mothers’ beliefs about and 
experiences of vaccination and HPV-related diseases; interactions with clinicians, 
friends and family members, and exposure to media reports/marketing about the HPV 
vaccine influenced their decisions (Griffioen et al 2012:561). 
 
In Japan, Hanley, Yoshiaka, Yoshiya, Konno, Hayashi, Kishi and Sakuragi (2012:916) 
examined Japanese mothers’ acceptance of and attitudes towards HPV vaccination of 
their adolescent daughters. The study wished to identify socio-demographic and 
attitudinal predictors associated with HPV vaccination acceptance. The study found that 
the majority of the mothers would vaccinate their daughters if the vaccine was free; the 
acceptance rate was higher among mothers who had heard about the HPV vaccine or 
when a doctor or local health board had recommended it. The study also found that the 
side effects of the vaccine were a barrier to vaccination. These findings confirm that 
knowledge is very important for parents to make sound decisions. 
 
Parents who had knowledge about HPV and the HPV vaccine had a positive attitude 
and took their daughters for HPV vaccination which is a positive behaviour. In addition, 
parents with a high educational level took their daughters for immunisation. 
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1.2 BACKGROUND TO THE STUDY 
 
Botswana is a middle-income country situated in Sub-Saharan Africa.  The country has 
a high incidence of HPV infections and cervical cancer. Botswana has a population of 
773418 women aged 15 and older who are at risk of developing cervical cancer (ICO 
Information Centre on HPV and cervical cancer [ICO fact sheet] 2017). An estimated 
250 women are diagnosed with cervical cancer annually and 111 of them die 
(Information Fact CO Information Centre on HPV and cervical cancer [ICO fact sheet] 
2014). Moreover, cervical HPV infection is a burden in Botswana, accounting for 53% of 
women tested (95% Confidence Interval [CI]) (ICO 2014).  
 
The high prevalence of HPV contributes to increased morbidity and mortality of cervical 
cancer. The HPV vaccine was licensed in Botswana in 2009, and is now given free to 
adolescent girls aged 9 to 13 years as a preventive strategy against HPV. The Ministry 
of Health introduced the Gardasil vaccine and vaccination programme (see chapter 2). 
The programme targets girls at primary school and out-of-school aged 9 to 13 years. 
The roll-out started in March 2013 and girls receive three doses of the vaccine.  
 
A study to assess the acceptability of the HPV vaccine among parents and adults 
attending a public hospital, before the inclusion of HPV vaccine in the Botswana 
national cancer prevention programme, concluded that the HPV vaccine was highly 
accepted if it became widely available to the daughters of healthcare-seeking parents in 
Gaborone (Ramogola-Masire 2014:82-83).  
 
The magnitude of cervical cancer in Botswana raised the following questions in the 
researcher’s mind: Do people know about HPV, and that it causes cervical cancer? Do 
they know that cervical cancer is preventable using the HPV vaccine according to the 
programme? Girls are at risk of contracting HPV which can lead to cervical cancer and it 
is the responsibility of parents to make sure that their daughters are vaccinated against 
HPV. Parental consent is required for vaccination of adolescent girls. Parents are key 
decision makers therefore they should have the necessary information in order to make 
informed decisions. Parents’ decision to vaccinate their daughters plays a crucial role in 
the successful implementation of the prevention programme. The public health benefit 
of the prophylactic vaccination can be achieved if parents have knowledge and positive 
attitudes towards the HPV vaccine. This motivated the researcher to conduct a study on 
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the knowledge, attitude and behaviour towards HPV and HPV vaccine among parents 
with adolescent girls aged 9 to 13 in Sefhare village, in Tswapong area in the Central 
District of Botswana. Sefhare falls under the Mahalapye District Health Management 
Team and the Mahalapye East catchment area. There is one primary hospital and five 
(5) mother clinics, of which four (4) have a maternity wing, and seven (7) health posts. 
In 2011, Sefhare had a population of 4602, consisting of 2050 males and 2552 females 
(Population and Housing Census 2011:100). 
 
1.3 STATEMENT OF THE PROBLEM 
 
A research problem is “a troubling condition which can be solved by generating 
evidence through research” (Polit & Beck 2012:73). A problem statement “articulates 
the problem and describes the need for a study through the development of an 
argument” (Polit & Beck 2012:73).  There are increasing cases of HPV infections and 
cervical cancer in Botswana. Statistics indicate that 250 women are diagnosed with 
cervical cancer annually (ICO 2014:12, Raditsebe 2017:2). Cervical cancer claims the 
lives of women, which poses a threat to future generations and increases the health bill 
thereby impacting negatively on the economy of the country.   
 
The Government of Botswana makes provision for the HPV vaccine to be given to 
school-going girls aged 9-13 as prophylaxis to prevent cervical cancer. Parents’ consent 
is required for vaccination, however, which means that the parents should have the 
necessary knowledge in order to make informed decisions.  
 
With the increasing number of HPV infections and cervical cancer in Botswana, the 
researcher proposed to investigate the parents’ knowledge about HPV and the HPV 
vaccine. Hence, the researcher conducted a study to assess the knowledge, attitudes 
and behaviour towards HPV vaccine. 
 
1.4 PURPOSE AND OBJECTIVES OF THE STUDY 
 
The purpose of the study was to determine the knowledge, attitude and behaviour of 
parents towards HPV and the HPV vaccine in preventing cervical cancer in girls aged 9 
to 13 years in Sefhare, Botswana. The study evaluated the uptake of the HPV vaccine 
and implementation of prevention strategy. 
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In order to achieve the purpose, the objectives of the study were to: 
 
 Determine the level of knowledge of parents of adolescent girls between the 
ages of 9 to 13 years regarding HPV and HPV vaccine. 
 Assess the attitudes of parents with adolescent girls aged 9 to 13 years towards 
HPV and HPV vaccine and their willingness to take their daughters for 
vaccination. 
 Determine parents’ behaviour in uptake of HPV vaccine. 
 Make recommendations based on the findings. 
 
The study wished to answer the following questions: 
 
 Do parents know about HPV infections and the HPV vaccine? 
 What is their attitude and behaviour towards HPV and HPV vaccination?  
 
1.5 SIGNIFICANCE OF STUDY 
 
The findings from this study will contribute to the body of knowledge on HPV and the 
HPV vaccine, particularly in Botswana. Parents would be aware and knowledgeable 
about HPV and the HPV vaccine thereby contributing to reducing the incidence of HPV 
infections and cervical cancer.  
 
The study should raise awareness of early cervical cancer screening. This would reduce 
the health bill for the country. The findings should help in identifying areas that need 
emphasis in preventing cervical cancer by addressing areas that need improvement. 
The findings should lead to improved effectiveness and implementation of the 
programme and improved immunisation coverage. Unimmunised girls who are eligible 
for immunisation will be identified and assisted accordingly.  
 
1.6 RESEARCH PARADIGM  
 
A paradigm is a worldview, a general perspective on the complexities of the world (Polit 
& Beck 2012:11). Polit and Beck (2012:15) add that paradigms are lenses helping to 
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sharpen the researcher’s focus on a phenomenon. Paradigms for humans are 
characterised by terms in which they respond to philosophical questions; such as, what 
is the  nature of reality (ontology) and what is the relationship between the inquirer and  
those being studied (epistemology) (Polit & Beck 2012:11).   
 
The positivism paradigm, also called logical positivism, has been used for nursing 
research for many years. Positivism emphasises the rational and the scientific (Polit & 
Beck 2012:12). In positivism, an assumption is believed to be true without proof or 
verification. Positivists believe phenomena or occurrences are not haphazard, but have 
antecedent causes. This is referred to as determinism. There must be a reason or 
reasons why something happens. The positivist approach involves using orderly, 
disciplined procedures with tight controls of the research to test researchers’ 
perceptions about the phenomena being studied and relationships among them (Polit & 
Beck 2012:12). 
 
In positivism there is another paradigm called postpositivism. Postpositivists believe in 
reality and the desire to understand it. They view objectivity as a goal and try to be as 
unbiased as possible. Evidence for a study is collected according to an established plan 
using structured methods to collect needed information (Polit & Beck 2012:14). 
 
Hence, this study adopted the post-positivism approach. Evidence of the study was 
collected using formal instrument to collect data. Furthermore, a structured 
questionnaire was used for data collection and the data was analysed using statistical 
procedures. In this study, the researcher acknowledged that for parents to make good 
decision about vaccinating their daughters they should have knowledge about HPV 
infections and the HPV vaccine. A positive attitude towards the HPV vaccine would 
result in the positive behaviour of having the girls vaccinated. There is a relationship 
between knowledge, attitude and behaviour. There is a relationship between 
educational level and HPV vaccine uptake.   
 
1.7 THEORETICAL FRAMEWORK  
 
A framework is the overall conceptual underpinnings of the study. A theory is a set of 
interrelated hypotheses, concepts, constructs, definitions and propositions that present 
a systematic review of phenomena based on facts and observations, with the purpose 
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of explaining and predicting the phenomena (De Vos, Strydom, Fouché & Delport 
2011:37). In a study based on a theory, the framework is referred to as a theoretical 
framework (Polit & Beck 2012:128). A theoretical framework is based on prepositional 
statements resulting from an existing theory. It helps the researcher to organise the 
study and provide a context in which a problem is examined, and data is collected and 
analysed (Brink, Van der Walt & Van Rensburg 2006:24). Polit and Beck (2012:126) 
describe a theory as an abstract generalisation that systematically explains how 
phenomena are interrelated.   
 
The researcher used the revised Health Belief Model as the theoretical framework for 
the study. Becker’s Health Belief Model is a framework for explaining people’s health-
related behaviour, such as health care use and compliance with a medical regimen. The 
model states that health-seeking behaviour is influenced by a person’s perception of a 
threat posed by the health problem, and the value associated with actions aimed at 
reducing the threat (Polit & Beck 2012:136).  
 
The revised Health Belief Model incorporates self-efficacy. The researcher considered 
the revised Health Belief Model appropriate for the study to explain the parents’ 
behaviour in relation to HPV vaccine uptake and their compliance. Compliance was 
evidenced by completion of three doses. 
 
Socio-demographic factors have an influence on perceived vulnerability, severity, 
benefits and barriers.  Regarding perceived vulnerability, if the parents had a negative 
attitude to or belief about the HPV vaccine, such as thinking that it could lead to 
promiscuity when given to young girls, they might have a negative attitude hence a 
negative behaviour. Regarding perceived severity, if the parents knew about HPV and 
that it poses a threat of causing cervical cancer, they would allow their daughters to be 
vaccinated to reduce the threat. If the parents believed that there were some health 
benefits of HPV vaccination that would positively influence their behaviour. Perceived 
barriers like transport or access to HPV vaccination might also have an influence on 
their behaviour. The health workers and media reminders would lead to positive 
behaviour in receiving HPV vaccination thereby reducing cervical cancer incidence. The 
parents were allowed to demonstrate self-efficacy by allowing them to make an 
independent decision to take their daughters for vaccination and to participate in the 
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study. The parents also made the decision to allow their daughters to be vaccinated. 
Figure 1.1 shows the Health Belief Model as it applied to HPV vaccination in this study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Health Belief Model applied to HPV vaccination  
(Thomas et al 2012:363) 
 
1.8  RESEARCH DESIGN AND METHODOLOGY 
  
A research design is the overall plan for obtaining answers to research questions (Polit 
& Beck 2012:58). It is the architectural backbone of the study and indicates where the 
study will take place, and how data will be collected. The researcher used a 
quantitative, descriptive, cross-sectional study design. A descriptive design enables 
researchers to describe variables in order to answer research questions with no attempt 
at establishing a cause-effect relationship (Brink et al 2006:102). 
 
The research methodology refers to the steps, procedures and strategies used to 
structure a study and to collect and analyse data relevant to the research questions 
(Polit & Beck 2012:12). The research methodology includes the population; sample and 
sampling; data collection and analysis; validity and reliability; pilot study or pre-test, and 
Perceived vulnerability, e.g. 
HPV attitudes, beliefs and 
perceived norms  
Perceived severity e.g. 
knowledge of HPV and 
cervical cancer 
Cues to health-
workers/media 
personal influence 
reminders 
Perceived benefits, e.g. 
avoiding cancer and genital 
warts  
Perceived barriers, e.g.  
cost, transportation or 
access self-efficacy 
Behaviour to 
reduce threat 
based on 
expectations HPV 
vaccination   
Sociodemo-
graphic 
factors 
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ethical considerations. Chapter 3 discusses the research design and methodology in 
detail.  
 
1.9 SCOPE OF THE STUDY 
 
The study investigated the knowledge, attitudes and behaviour towards HPV and the 
HPV vaccine among parents with adolescent girls aged 9 to 13 years in Sefhare village. 
The respondents consisted of parents residing in Sefhare. The number of adolescent 
girls whose parents participated in the study was calculated in order to assess the HPV 
vaccine uptake. 
 
1.10 ETHICAL CONSIDERATIONS  
 
When humans are used as study respondents care must be taken in ensuring that their 
rights are protected (Polit & Beck 2012:748). Accordingly, the researcher obtained 
permission to conduct the study and observed the ethical principles of beneficence, 
justice, autonomy and anonymity (Polit & Beck 2012:748). Chapter 3 discusses the 
ethical considerations in full. 
 
1.11 DEFINITION OF KEY TERMS 
 
For the purposes of this study, the following terms were used as defined below: 
 
Adolescent: The WHO (2009:6, 7) refers to young persons aged 10 to 19 years as 
adolescents. In this study, adolescent referred to girls between 9 and 13 years old in 
Sefhare in Botswana.  
 
Attitude: Attitude is defined as “the opinions and feelings that one usually has about 
something especially when this is shown in one’s behaviour” (Longman Dictionary of 
Contemporary English 2011:94). In this study, attitude referred to the feelings or 
opinions of parents about HPV and the HPV vaccine, how they perceived HPV and 
whether they accepted the HPV vaccine or not. 
 
Behaviour: Behaviour is defined as “the things that a person or animal does” (Longman 
Dictionary of Contemporary English 2011:137). In this study behaviour referred to what 
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parents did with regard to taking their daughters for vaccination; that is, whether they 
took their daughters for vaccination or not. 
 
Cervical cancer: Cervical cancer is an “uncontrolled growth of cells on the cervix” 
(Botswana Ministry of Health 2014:7) The Oxford Medical Dictionary (2015:135) defines 
cervical cancer as “cancer of the neck of the uterus”.  
 
Human papillomavirus (HPV). Human papillomavirus (HPV) is the name given to a 
group of more than 200 sexually transmitted viruses spread through skin-to-skin contact 
during sexual activity (Ministry of Health Botswana 2014:8). HPV cause cervical cancer, 
and the HPV vaccine is used to prevent it. 
 
Knowledge: Knowledge is “the information, skills and understanding that one has 
gained through learning or experience” (Longman Dictionary of Contemporary English 
2011:969). In this study, knowledge referred to what the parents understood or 
information they had regarding cervical cancer, HPV and the HPV vaccine. 
 
Parent: Someone who takes care of and raises a child or relative or guardian who plays 
the role of the parent. In this study, parent referred to anyone above 18 years who lived 
with the child and took the responsibility of making decisions regarding HPV vaccine 
uptake. 
 
Uptake: Uptake means “the number of people who use a service or accept something 
that is offered” (Longman Dictionary of Contemporary English 2011:1935). In this study, 
uptake referred to the number of parents who accepted the HPV vaccine and daughters 
who received the HPV vaccine. 
 
Vaccine: A vaccine is “a substance which contains a weak form of the bacteria or virus 
that causes a disease and is used to protect people from that disease” (Longman 
Dictionary of Contemporary English 2011:1940). In this study, the HPV vaccine referred 
to the substance used to protect adolescents from cervical cancer. 
 
1.12 STRUCTURE OF THE DISSERTATION 
 
The dissertation consists of five chapters:  
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Chapter 1 Orientation to the study 
Chapter 2 Literature review 
Chapter 3 Research design and methods  
Chapter 4 Data analysis, interpretation and findings 
Chapter 5 Conclusion and recommendations 
 
1.13 CONCLUSION 
 
HPV infections and cervical cancer are of grave concern and a heavy burden in 
Botswana and worldwide. It is evident that awareness and knowledge play a vital role in 
parents’ attitude and willingness to vaccinate their daughters against HPV.  This chapter 
discussed the problem, purpose, objectives and significance of the study. The research 
paradigm, theoretical framework, research design and methodology and ethical 
considerations were briefly described and key terms defined. 
 
Chapter 2 discusses the literature review conducted for the study. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
This chapter discusses the literature review conducted for the study. A literature review 
helps researchers to easily understand the meaning and nature of the identified 
research problem (De Vos et al 2011:134). The purpose of the review is to convey what 
is currently known on the topic of interest. In addition, it assists researchers to 
comprehend and extend their knowledge of the phenomenon under study (Polit & Beck 
2012:105). The literature review covered HPV and HPV vaccines; the incidence and 
prevalence of HPV and cervical cancer; transmission of HPV, and knowledge, attitudes 
and behaviour towards HPV and the HPV vaccine. 
 
2.2 HUMAN PAPILLOMAVIRUS (HPV) 
 
Human papillomavirus (HPV) is the name given to a group of more than 200 sexually- 
transmitted viruses spread through skin-to-skin contact during sexual activity (Ministry of 
Health Botswana 2014:8). HPV is the most common cause of sexually-transmitted 
diseases in both men and women. It is the established causative agent of cervical 
cancer, anal and penile cancers as well as genital warts in both men and women. HPVs 
are categorised as cutaneous or mucous types. Cutaneous types target the skin of the 
hands and feet. Mucous types infect the mouth, throat, respiratory tract and ano-genital 
epithelium. Based on their association with cervical cancer and pre-cancer lesions, 
HPVs can be grouped into low and high risk. High risk HPVs include types 16 and 18 
which are mostly associated with cervical cancer. Estimates show that 50 % of sexually 
active men and women will have at least one HPV infection at some point in their lives 
(Botswana Ministry of Health 2014b). HPV infection can be cleared away naturally, but 
may persist and progress to cervical cancer if not treated. HPV has no cure. 
 
There is a worldwide high incidence rate of HPV infections and cervical cancer. 
Globally, an estimated 500,000 new cases and 274,000 deaths occur annually (Turiho 
et al 2014:45). 
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Statistics indicate increased incidence and deaths from cervical cancer. In the 
Sustainable Development Goals, 2030-2035, the World Health Organization (WHO) 
emphasises the necessity of addressing cervical cancer (Richter 2015:1).  
 
The fight against cervical cancer includes early detection. The routine prevention of 
cervical cancer is through a Pap smear and visual inspection using acetic acid (VIA). In 
Botswana this is commonly known as the ‘see and treat’ programme, because women 
come to clinic, get screened and treated if there is evidence of pre-cancer.  
 
In response to the increased mortality rate, many countries adopted the HPV vaccine as 
a preventive strategy against HPV infections, cervical cancer and related diseases, to 
vaccinate girls before they are sexually active. The age at vaccination differs from 
country to country. In Botswana, the HPV vaccine is administered to adolescent girls 
aged 9 to 13 years, who are in Standards 4, 5 and 6, respectively. Several studies have 
been conducted to assess parents’ awareness and knowledge of and attitudes towards 
HPV and the HPV vaccine 
 
2.3 HPV VACCINE AS A PREVENTIVE STRATEGY  
 
In 2006, the United States of America was the country to approve the quadrivalent 
vaccine for females, extending this approval to use in males in 2009 (Fu, Bonhomme, 
Cooper, Joseph & Zimet 2014:1901). By 2014 more than 57 countries had included the 
HPV vaccine in their national health programmes (Herrero, Gonzalez & Markowitz 
2015:e206). Cervarix (bivalent) and Gardasil (quadrivalent) vaccines are used for 
preventing HPV infections. Both the bivalent and quadrivalent vaccines induce a strong 
immune response against HPV types as well as partial cross-protection against 
phylogenetically related non-vaccine HPV types. The vaccines are administered in three 
doses. The first dose is given at initial contact with the adolescent. The second dose is 
given two months after the initial dose and the third dose is given four months after the 
second dose.  
 
Clinical trials indicated that three vaccine doses provide 90% to 100% protection against 
cervical infection and pre-cancer related to HPV 16 and 18 (Herrero et al 2015e:206). 
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To be fully protected, one must get all three doses. To maximise effectiveness, the 
vaccine is given to adolescent girls before they are sexually active.  
 
2.3.1 Gardasil 
 
Gardasil vaccine contains 6, 11, 16 and 18 antigens. The quadrivalent vaccine protects 
against cancer of the cervix, vagina, vulva and anus, and genital warts. It induces a 
strong immune response against HPV types. The quadrivalent vaccine is produced in 
yeast (Saccharomyces cerevisiae) and has an aluminium hydro phosphatesulphate 
adjuvant (Herrero, Gonzalez & Markowitz 2015:e207). Gardasil is a recombinant 
vaccine made of virus-like particles (VLPs) (Botswana Ministry of Health 2014a:11). 
Gardasil is indicated for girls and women aged 9 to 26 years. 
 
2.3.2 Cervarix 
 
Cervarix contains HPV 16 and 18 antigens. The bivalent vaccine is produced in 
Trichoplusiani insect cell lines infected with an L1 baculovirus vector and has a special 
adjuvant called ASO4, consisting of monophosphoryl lipid A and aluminium hydroxide 
(Herrero et al 2015:e207). 
 
Protection against strains of HPV that lead to cervical cancer and cause genital warts 
can be achieved through immunisation with the HPV vaccine. HPV infections can also 
be prevented by consistent use of condoms.  HPV vaccine protects one from 
contracting certain types of HPV and HPV-related diseases. Clinical trials found the 
vaccines safe, well tolerated and highly effective in preventing HPV 16 and 18 infections 
and related precancerous lesions.  
 
2.4 BACKGROUND TO THE HPV VACCINE 
 
The HPV vaccine is used as a preventive strategy against cervical cancer in adolescent 
girls. It has been used in Canada, the USA and Australia since 2006. Clinical trials 
conducted to evaluate the efficacy of the vaccines found them to be safe and tolerated. 
Vaccines are most successful and cost-effective public health interventions available to 
avert vaccine-preventable diseases and deaths (Abdullahi, Kagina, Cassidy, Adebayo & 
Hussey 2016:3950). 
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2.5 INCIDENCE AND PREVALENCE OF HPV INFECTION AND CERVICAL 
CANCER 
 
The incidence and prevalence of HPV infections and cervical cancer are of grave 
concern. Globally, about 500,000 new cases and 274,000 deaths occur annually (Turiho 
et al 2014:45). More than 80% of the deaths occur in developing countries, where 
cervical cancer is the leading cause of cancer deaths among adult women (Turiho et al 
2014:45). Approximately 530,232 new cases are diagnosed annually and over 275,000 
women die every year, and 85% of these are in developing countries (Mouallif et al 
2014:409). In France, an estimated 2,800 new cases were diagnosed in 2011, leading 
to 1,000 deaths (Haesebaert et al 2012:2).  In North India, Hussain et al (2014:1) found 
that in 80% of sexually active women persistent HPV infection led to invasive cervical 
cancer. In Morocco, cervical cancer is a major public problem and is ranked second to 
breast cancer in women in terms of incidence and mortality with approximately 1,979 
new cases and 1,152 deaths each year, and incidence and mortality rates of 14.1 and 
8.4 per 100,000 (Mouallif et al 2014:409). 
 
In South Africa, more than 7,700 women are diagnosed with cervical cancer every year, 
of who more than half ultimately die of the disease (Richter 2015:1). In Zambia, an 
estimated 2,330 women are diagnosed with cervical cancer and 1,380 die from the 
disease every year (ICO [fact sheet] 2016). Approximately 2,270 women are diagnosed 
with cervical cancer and 1451 die from the disease in Zimbabwe every year (ICO [fact 
sheet] 2016). In Botswana, 250 women are diagnosed with cervical cancer annually and 
111 deaths reported. HPV infections are reported at 53% (95% confidence interval) 
(ICO 2014). 
 
2.6 HPV AND CERVICAL CANCER 
 
Persistent infection with oncogenic HPV may lead to the development of cervical 
cancer. HPV-16 and HPV-18 are the most prevalent in cervical cancer, accounting for 
approximately 70% of cases worldwide (Jaisamrarn, Castellague, Garland, Naude & 
Palmroth 2013:e798260). Most HPV infections go away on their own within one to two 
years and do not cause cancer (Botswana Ministry of Health 2014:9). Persistent HPV 
infection causes cervical changes which may lead to pre-cancer.  
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Cervical pre-cancer is not actually cancer, but may develop into cancer with time.  
Infection with HPV may take place during the teenage years and become cervical 
cancer in the 30s or 40s. For this reason, it is necessary to prevent HPV infection at an 
early age before sexual debut.  
 
In HIV-positive women it takes even less time for the virus to cause cervical cancer 
(Raditsebe 2017:2). HPV does not produce any symptoms until at advanced stages 
when it has caused cervical cancer (Raditsebe 2017:2).  
 
2.7 HPV/CERVICAL CANCER TRANSMISSION AND PREVENTION 
 
HPV is transmitted sexually through skin contact. Men carry the virus and transmit it to 
women during the sexual act. HPV and cervical cancer can be prevented through 
abstinence, consistent use of condoms, and the HPV vaccine. Areas that are not 
covered by a condom are not protected. Routine prevention of cervical cancer is 
achieved by cervical screening and Pap smears which are done every three years. 
Visual inspection using acetic acid (VIA) and treatment with nitrous oxide for pre-cancer 
is also used. Pap smears and VIA check if the virus has caused any abnormal changes 
in the cervix associated with cervical cancer (Raditsebe 2017:2). Other ways to prevent 
cervical cancer include lifestyle and behavioural changes, including reducing sexual 
partners, no smoking and delaying age of sexual debut. 
 
2.8 PARENTS’ KNOWLEDGE, ATTITUDES AND BEHAVIOUR  
 
In 2012, Haesebaert et al (2012:1-10) investigated French women’s knowledge and 
attitudes towards cervical cancer prevention and HPV vaccination acceptability. The 
study used a quantitative-qualitative, cross-sectional design and a self-administered 
questionnaire. Semi-structured interviews were used to collect data.  One of the 
objectives was to assess French mothers’ knowledge of cervical cancer, Pap smears 
and HPV vaccination and their acceptance of HPV vaccination for their 14 to 18 year-
old daughters (Haesebaert et al 2012:2). Of the respondents, 61% knew about Pap 
smears; 16.9% knew the causes of cervical cancer, and 76.2% were aware of the HPV 
vaccine. Of the respondents, 54.7% had heard about the vaccine from television and 
16.0% had heard from their doctors. Regarding acceptability of the vaccine, 2% were 
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opposed, 40.2% were undecided, and 58.8% were in favour of the vaccine. The study 
found that most of the mothers supported HPV vaccination, which was a positive 
attitude. Haesebaert et al (2012:2) found a positive relationship between knowledge and 
attitude, and that attitude influences behaviour. The mothers’ awareness and knowledge 
of the vaccine made them willing to vaccinate their daughters. 
 
Hanley, Yoshioka, Ito, Konno et al (2012:912-916) conducted a study on the 
acceptance of and attitudes towards HPV vaccination in Japanese mothers of 
adolescent girls aged 11 to 14. This was a school-based survey and self-administered 
questionnaires were used. The aim of the study was to examine the mothers’ attitudes 
to HPV and the HPV vaccine; determine acceptance of and preferences for HPV 
vaccine, and identify socio-demographic and attitudinal predictors associated with HPV 
vaccination acceptance (Hanley et al 2012:913). Of the mothers, 52.0% had heard 
about the HPV vaccine and 92.6% would vaccinate their daughters if the vaccine was 
free. The acceptance rate of the vaccine was higher in the mothers who had heard 
about it. Recommendation from a doctor and local health board were positively 
associated with high HPV vaccine acceptance.  
 
Regarding the efficacy of the vaccine, 98.2% of the mothers believed that it would offer 
high protection and 96.6% believed it would offer moderate protection. The side effects 
of the vaccine were reported as an obstacle to vaccination. These findings indicate that 
parents’ awareness and knowledge results in the positive behaviour of vaccinating their 
daughters. Knowledge is very important for parents to make sound decisions.  
 
In Ontario, Canada, Okoronkwo, Sieswerda, Cooper, Binette and Todd (2012:117-126) 
examined the role of knowledge and attitudes on parents’ consent to HPV vaccination of 
their daughters.  Of the 188 respondents, 126 gave consent for their daughters to be 
vaccinated, while 62 declined. Those who declined had negative attitudes towards the 
HPV vaccine. The results indicate the effect of knowledge on the decision to give 
consent was confounded by strong negative attitudes (Okoronko et al 2012:126). 
 
Ayissi, Wamai, Oduwo, Perlman, Welty, Welty, Manga & Ogembo (2012:1127-1135) 
investigated awareness, acceptability and uptake of HPV vaccine among Cameroonian 
school-attending females. This was cross-sectional study and questionnaire survey was 
used to collect data. The purpose of the study was to assess awareness, knowledge 
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and beliefs about HPV, cervical cancer HPV vaccine and willingness to vaccinate 
among adolescent females in North-West Cameroon (Ayissi et al 2012:1127). Of the 
respondents, 83.5% knew that everyone is susceptible to HPV infection; 82.3% were 
aware that certain HPV genotypes cause cervical cancer; 75.9% were aware that the 
HPV vaccine prevents HPV infection; 75.6% knew that an abnormal Pap test may be a 
sign of an HPV infection, and 34.2% had been vaccinated. Furthermore, of the 
respondents, 45.6% of adolescents strongly recommended and 33.1% recommended 
that girls 9 to 13 years be vaccinated against HPV infections. These findings indicate a 
positive relationship between knowledge, attitude and behaviour. 
 
In 2013, Kornfeld, Byrne, Vanderpool, Shin and Kobertz (2013:59-69) in USA conducted 
a study on HPV knowledge and vaccine acceptability among Hispanic fathers. A cross-
sectional study was used, telephone interview was used to collect data. The purpose of 
the study was to examine the fathers’ knowledge of HPV and the vaccine and their 
willingness to have their adolescent daughters vaccinated (Kornfeld et al 2013:59).  
 
  Of the respondents, 84.4% knew that multiple sex partners increased the risk of HPV 
infection and cervical cancer, and that it could be prevented by using condoms, and 
87.3% had heard about the Pap smear test.  Among those aware of HPV, 52.7% were 
also aware of the HPV vaccine (Gardasil). Of the respondents, only 29.2% had high 
knowledge about HPV and the vaccine. With regard to attitude, 93.4% of the 
respondents agreed or strongly agreed to the HPV vaccine, and 78.8% were willing to 
have their daughters vaccinated. Kornfeld et al (2013:69) found a low awareness and 
knowledge of the HPV vaccine. Despite low levels of awareness and knowledge, 
however, most of the respondents showed a positive attitude towards the HPV vaccine, 
as evidenced by their willingness to vaccinate their daughters.  
 
In 2014, Hussain, Nasare, Kumari, Sharma, Khan, Das and Bharadwaj (2014:e112) 
conducted a survey in Delhi and NCR regions of North India on perceptions of HPV, 
cervical cancer and HPV vaccination. The objective of the study was to assess 
knowledge about cervical cancer, HPV awareness, and HPV vaccine acceptance 
among high school to undergraduate students and their parents’ perceptions and 
acceptance of the HPV vaccine. Of the student respondents, 69% of the females and 
31% of the males knew about cervical cancer, while 72% of the females and 28% of the 
males were aware that the HPV vaccine was available. Of the female respondents, 70% 
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were willing or agreeable to HPV vaccination. Regarding the parent respondents, 13% 
agreed to vaccinate their daughters. These findings also confirmed a positive 
association between knowledge, attitudes and behaviour or practice.  
 
In a comparative survey, Turiho et al (2014:45-53) investigated the effects of school-
based HPV vaccination on adolescent girls’ knowledge and acceptability of the HPV 
vaccine in Ibanda, Uganda. The study used a comparative, cross-sectional mixed 
method. Self-administered were to collect data.  This was comparison between Ibanda 
and Mbarara districts, where Ibanda was the vaccine district while Mbarara was the 
comparison district. The respondents consisted of 777 girls: 444 from Ibanda and 333 
from Mbarara districts. The results revealed that the girls who were vaccinated were 
more knowledgeable about cervical cancer and the HPV vaccine than their 
unvaccinated counterparts. There was not much difference in the acceptance rate 
between the vaccinated and unvaccinated girls, as 92.5% of the unvaccinated girls 
compared to 89% of the vaccinated girls were in favour of the vaccine. Turiho et al 
(2014:53) found no relationship between knowledge and acceptability given the slight 
difference in percentage between the two groups. Here there was no association 
between knowledge and attitude. 
  
Perlman et al (2014:e90912) conducted a systematic review of knowledge and 
awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa. The 
review covered 26 studies in 13 countries which investigated the knowledge and 
awareness of cervical cancer, HPV and HPV vaccine, willingness and acceptability to 
vaccinate. Eleven out of 15 studies showed high awareness; 9 showed low awareness, 
and 2 showed moderate awareness, respectively. Sixteen studies assessed knowledge 
of cervical cancer and revealed low levels of knowledge, with 3 reporting no knowledge 
and 2 reporting moderate knowledge. Twelve studies examined willingness and 
acceptability of HPV vaccine and all revealed high levels of acceptability of the vaccine. 
The review indicated that despite low levels of awareness and low knowledge, the 
acceptance rate and willingness to vaccinate daughters was high. Perlman et al (2014) 
found no relationship or association between knowledge and attitude. 
 
In Zambia, Milimo et al (2015:85-92) conducted a descriptive cross-sectional study on 
knowledge and attitudes towards the HPV vaccine. Questionnaires were used for data 
collected. The study took place in Chipata, Monze, Lusaka and Namwala districts in 
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order to determine the knowledge and attitudes of parents/guardians towards the HPV 
vaccine in preventing cervical cancer among school-going girls aged 9-13 years (Milimo 
et al 2015:85-92).  Of the respondents, 64% reported that they had heard about HPV; 
68.5% had heard about the HPV vaccine through various means including the media 
(35%); 74% knew that girls aged 9 to 13 years should be given the HPV vaccine and 
that it prevents girls from contracting HPV infection, and 66% knew that HPV could lead 
to cervical cancer. Of the respondents, 84% agreed that the HPV vaccine was helpful in 
preventing cervical cancer and was necessary to be given to girls aged 9 to 13 years, 
and 83% allowed the girls to be given the HPV vaccine. Regarding educational level, 
35% of the respondents had achieved a college education while 76.5% were formally 
employed. 
 
There was a significant association between the respondents’ knowledge scores and 
age, educational level and occupational status (Milimo et al 2015:92). Milimo et al’s 
(2015:92) findings show that the respondents (parents) had knowledge about HPV and 
the HPV vaccine and therefore had a positive attitude towards the vaccine. This 
confirmed a positive relationship between knowledge and attitude. It also indicated a 
positive relationship between education and attitude as evidenced the respondents 
allowing their daughters to be vaccinated. 
 
A systematic review of knowledge, attitudes and practices on adolescent vaccination 
among adolescents, parents and teachers in Africa was conducted by Abdullahi, et al 
(2016:3950-3960).  The objectives of the study were (a) to assess the knowledge, 
attitudes and practices among adolescents, parents and teachers on adolescent 
vaccination in Africa, and (b) to associate these among the key players with vaccination 
coverage among adolescents in Africa (Abdullahi et al 2016:3951-3952).  The review 
considered various adolescent vaccinations such as HPV, tetanus, toxoid, rabies, HIV 
and tuberculosis (TB). The review included 18 carried out in ten African countries. Of 
the studies, 72% (n=13) investigated the HPV vaccine, while the remaining 28% (n=5) 
investigated TB, tetanus, rabies, HIV and adolescent vaccines in general. 
 
For the purpose of this study, the literature review focused on the 13 studies that 
investigated the HPV vaccine. 
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The aim of these studies was to assess the knowledge, attitude and 
awareness/acceptability of the HPV vaccine. In all the studies, the respondents were 
not aware of the HPV virus and HPV vaccine, but were aware of cervical cancer. It was 
observed that level of knowledge amongst parents, adolescents and teachers ranged 
between low, moderate and high. Knowledge was considered low when less than 50% 
of the respondents had sufficient knowledge on specific information of the vaccine. Of 
the studies, 17% showed high levels of knowledge among parents and adolescents, 
while 28% showed moderate levels of knowledge among teachers and adolescents. Of 
the adolescents, 58% showed a positive attitude towards the HPV vaccine. A negative 
attitude towards the HPV vaccine was obtained in 11% of the studies.   
 
In 12 studies, the adolescents highly accepted the HPV vaccine. The parents also 
showed a willingness to have the adolescents vaccinated. The parents’ attitudes were 
not reported in the review. Despite the low levels of awareness and knowledge, the 
studies found a positive attitude and high acceptance of the HPV vaccine. The 12 
studies pointed to a positive attitude influencing good behaviour as demonstrated by the 
adolescents’ attitude and acceptance. 
 
In 2016, Yu, Xu, Sun, Li, Li, Wang, Zhang and Xu (2016:e0146741) conducted a cross-
sectional survey in Weihai, Shandong, China. The study used a cross-sectional survey 
and self-administered questionnaires were used to collect data. The study examined 
awareness and knowledge of HPV and acceptability of HPV vaccine among teenage 
daughters. The respondents included both urban (38.9%) and rural (45.94%) mothers of 
daughters aged 9 to 17 years. Of the respondents, 19.33% were aware of HPV and had 
heard about HPV; 14.75% had no knowledge of HPV and the HPV vaccine. The study 
found that 58.69% had low knowledge while 26.56% had high knowledge. The mothers 
with a higher educational level had high levels of knowledge and 26.49% expressed 
acceptance of the HPV vaccine and willingness to vaccinate their daughters. The study 
found poor awareness and knowledge and low acceptability of HPV and the HPV 
vaccine (Yu et al 2016:e0146741). 
 
In preparation for the introduction of HPV vaccines in Bamako Mali, De Groot, 
Tounkara, Rochas, Beseme, Yekta, Diallo, Tracy, Teguete and Koita (2017:e0171631) 
investigated the knowledge, attitudes, practices and willingness to vaccinate. The study 
used two standardized questionnaires in structured interviews. The respondents were 
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interviewed, and then an information and educational session was held. This was 
followed by a second questionnaire. The survey included adults aged 18 and older and 
adolescents aged 12 to 17 years. Of 301 respondents, 149 were females and 152 were 
males. The results showed that before the educational session, 8.6% (n=26) were 
aware of HPV. Knowledge among the adolescents was poor (5.3%). The respondents’ 
knowledge increased significantly after the educational session. The study found a high 
acceptance rate of the vaccine with 98.3% of the respondents being willing to vaccinate. 
De Groot et al (2017) found that the education session increased the respondents’ 
knowledge and led to acceptance of the vaccine and willingness to vaccinate. This 
indicated a positive relationship between knowledge and attitude. Knowledge influenced 
the attitude and practice/behaviour outcomes.  
 
2.9 CONCLUSION  
 
HPV infections and cervical cancer are a major concern. HPV vaccines provide 
protection against HPV infections. This chapter discussed the literature review on HPV 
and HPV vaccines.  
 
Chapter 3 describes the research design and methodology. 
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CHAPTER 3 
 
RESEARCH DESIGN AND METHODOLOGY 
 
3.1 INTRODUCTION 
 
This chapter describes the research design and methodology used, including the 
population, sampling and sample, data collection and analysis, trustworthiness, and 
ethical considerations. 
 
3.2 RESEARCH DESIGN  
 
A research design is “a set of logical steps taken by the researcher to answer the 
research question” (Brink et al 2006:92).  The research design is the overall plan for 
obtaining answers to the research questions. (Polit & Beck 2012:58).  It is the 
architectural backbone of the study and indicates how data will be collected and where 
the study will take place. In this study, the researcher selected a quantitative, 
descriptive and cross-sectional design.  
 
3.2.1 Quantitative  
 
The research design was quantitative because the researcher used structured 
procedures and a formal instrument to collect data that was then analysed by computer 
into numerical information through statistical procedures (Brink et al 2006:101). The 
researcher considered a quantitative approach appropriate for the study and a 
structured, self-designed questionnaire was used to collect data from the respondents. 
Quantitative research is mostly aligned with the positivist paradigm. Quantitative 
research is the investigation of a phenomenon that lends itself to precise measurements 
and justification, often involving a rigorous and controlled design (Polit & Beck 
2012:739). Quantitative research uses deductive reasoning to generate predictions. It 
typically moves in systematic fashion from definition and selection of concepts on which 
to focus to the solution of the problem. The investigator or researcher progresses 
logically through a series of steps, according to the plan of action.  
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Quantitative research uses empirical evidence. Research findings are grounded on 
reality rather than the researcher’s personal beliefs. Data gathered in quantitative 
studies is numeric and analysed statistically. To study a phenomenon, quantitative 
researchers attempt to measure it by attaching numeric values that express quantity 
(Polit & Beck 2012:739). 
 
3.2.2 Descriptive  
 
Descriptive research explores and describes phenomena in real-life situations (Polit & 
Beck 2012:725). A descriptive study sets out to quantify the extent of the health problem 
or the burden of disease (Elrich & Joubert 2014:79). This study described how much the 
parents knew about HPV and the HPV vaccine as well as their attitudes and behaviour 
towards HPV and the vaccine. Their responses were quantified.  
 
3.2.3 Cross-sectional  
 
In a cross-sectional study, the researcher obtains all relevant information from the 
respondents at a single point in time, and no future follow-up contacts are made (Polit & 
Beck 2012:184). Sullivan (2012:8) describes a cross-sectional study as one conducted 
at a single point in time. Furthermore, it is appropriate when the research question is 
focused on the prevalence of a disease, present practice or an opinion.  
 
The researcher considered a cross-sectional design appropriate in this study because 
the research question focused on the parents’ views, attitudes and practice with regard 
to the HPV vaccine. In a cross-sectional study, the researcher usually selects the 
sample without reference to exposure or disease. In addition, the sample may be drawn 
at random from a defined population or may be a naturally occurring sample (Elrich & 
Joubert 2014:81). Data was collected at one point in time from each respondent. The 
respondents selected had not necessarily been affected by HPV or cervical cancer.  
 
The study described the relationship between knowledge and attitudes; that is, if 
parents have knowledge about HPV and HPV vaccine, it is likely to influence their 
attitude and hence behaviour. It also described the relationship between the parents’ 
educational level and decision to take their daughters for vaccination. The study took 
place at Sefhare village in the Central District of Botswana. 
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3.3 RESEARCH METHODOLOGY 
 
Research methodology refers to the techniques researchers use to structure a study 
and to collect and analyse information relevant to the research question (Polit & Beck 
2012:12).  The research methodology includes the population, sample and sampling, 
data collection and analysis, and validity and reliability.  
 
3.3.1 Population and setting 
 
A population is the entire aggregation of cases in which a researcher is interested (Polit 
& Beck 2012:273). De Vos et al (2011:223) describe a population as individuals in the 
universe who possess specific characteristics. In this study, the population consisted of 
female and male parents/guardians of adolescent girls aged 9-13 years in Sefhare.  
 
The inclusion and exclusion criteria were based on the respondents’ ability to participate 
in the study and design consideration.  Consideration was also given to the subjects’ 
ability to comprehend the study information and the legal competence to give informed 
consent. Another important consideration was the health condition of the respondents, 
for example mental impairment, which could preclude participation (Polit & Beck 
2012:274). Hence, the parents/guardians who were deemed mentally impaired and 
those below 18 years were excluded from the study. The parents who were 18 years of 
age and above were included.  With regard to design considerations, a homogenous 
population of parents who have adolescent girls aged 9 to 13 years was included in the 
study. 
The setting is the physical location and conditions in which data collection takes place in 
a study (Polit & Beck 2012:743). This study took place in the respondent homes and 
only the respondents were present during the interview process.  
 
The place of the study was Sefhare village. The village is situated in the Central District 
of Botswana, in the Tswapong area. Sefhare falls under the Mahalapye District Health 
Management Team and the Mahalapye East catchment area. There is one primary 
hospital and five (5) mother clinics, of which four (4) have a maternity wing, and seven 
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(7) health posts. The village has a population of 4602 people, consisting of 2050 males 
and 2552 females (Population and Housing Census 2011:100). 
 
3.3.2 Sampling and sample 
 
Sampling is the process of selecting a part of the population to represent the total 
population so that inferences can be made about the population (Polit & Beck 
2012:275). A sample is a subset of population elements, which are the most basic units 
about which data are collected (Polit & Beck 2012:275). The sample was randomly 
selected using probability random sampling.  
 
A sample comprises elements or a subset of the population considered for actual 
inclusion in the study or can be viewed as a subset of measurements drawn from a 
population in which researchers are interested (De Vos et al 2011:223-224). In order to 
do sampling, a sampling frame is needed. A sampling frame refers to a list of elements 
from which the sample will be chosen (Polit & Beck 2012:280). The sample frame is a 
list of the study population (De Vos et al 2011:224). In this study, the sample frame 
consisted of parents of adolescent girls in four main wards (Kgotlas), namely Bobirwa, 
Maifala, Sefhare and Seruleng), in Sefhare. Stratified systematic sampling was used, 
and every fifth house was selected from each ward (kgotla). The parents/guardians 
were informed about the study in the main Kgotla and at the hospital. 
 
Prior to the sample selection process, the researcher informed the village and hospital 
authorities (the village chief and hospital matron) about the study and its objectives. The 
respondents were informed about the study at the main Kgotla and at Sefhare Primary 
Hospital during the health talks. The respondents were recruited face-to-face, in a 
pleasant and courteous manner. The researcher identified eligible candidates and 
asked their permission to join the study. The study information, objectives and where 
the interview would take place, were explained in detail to the respondents.  No 
incentives, monetary or otherwise, were used to recruit the respondents. 
 
3.3.3 Sample size 
 
There are no simple formulas that can tell the researcher how large a sample should be 
in a given study (Polit & Beck 2012:284). The larger the sample, the more 
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representative it is of the population (Polit & Beck 2012:284). The entire population was 
4,602; the researcher used a confidence level of 95%, margin of error of 10 percent and 
response distribution of 50%. The researcher calculated the sample size using the 
following formula: 
 
 
ss =  
Z 2 * (p) * (1-p)  
 
c 2 
 
Where: 
Z = Z value (A confidence interval of 95% was employed in this study, 1.96 was the Z 
value used to calculate the sample size)  
p = (.5 used for sample size needed) 
c = confidence interval (0.1 was used as the margin of error)  
 
Correction for finite population 
  
Ss 
 
new ss =  
 
  
1+ 
      ss-1 
 
Population 
 
 
The researcher selected a sample of 95 parents/guardians, calculated according to the 
formula. As a university requirement, 100 respondents were used. Twenty-five 
households from each kgotla participated in the study; every fifth household was 
selected. 
 
3.3.4 Data collection 
 
Data collection is the precise, systematic gathering of information relevant to the 
research purpose or objectives of the study (Polit & Beck 2012:723). Data was collected 
by means of face-to-face interviews, using a structured self-administered questionnaire. 
According to Polit and Beck (2012:723), when structured questionnaires are used, the 
respondents are asked to respond to similar questions, in the same order and with the 
same set of response options. The interviews were conducted in the respondents’ 
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households. The researcher explained the purpose of the study, that participation was 
voluntary and that they could withdraw from the study at any time should they wish to do 
so. The respondents signed a consent form before the interview. No one was present 
during data collection.  At the end of the interview, the researcher explained the correct 
answers to the respondents so that they were left knowledgeable.  
  
3.3.4.1 Data-collection instrument 
 
The researcher developed a questionnaire containing closed and open-ended questions 
(Polit & Beck 2012:298).  The questionnaire consisted for four sections (see Annexure 
D):  
 
 Section 1 - Demographic data:  Respondents’ age, gender, educational level and 
ward  
 Section 2 - Knowledge of HPV: Respondents’ knowledge of HPV infection, 
cervical cancer and the HPV vaccine 
 Section 3 - Attitude: Respondents’ attitudes towards HPV, cervical cancer and 
the HPV vaccine, including how respondents perceived the severity and 
susceptibility to HPV infections and cervical cancer 
 Section 4 - Behaviour: Respondents’ behaviour regarding HPV vaccination. 
 
The researcher submitted the questionnaire to the supervisor for review and approval. 
The researcher sent the questionnaire to the UNISA Ethical Committee for Higher 
Degrees and the Ministry of Health and Wellness (Botswana) for review.  
 
3.3.4.2 Pre-test or pilot study  
 
A pre-test or pilot study is a trial run to determine whether the instrument is clearly 
worded and free from major biases and whether it solicits the desired information (Brink 
et al 2006:94).  It provides an opportunity to try out the technique or instructions that will 
be used with an instrument, especially if the instrument has not been used with a 
specific population, as in the case of this study. The purpose is not to collect data but to 
identify problems that the potential respondents might have in either understanding or 
interpreting any questions. In this study the researcher conducted a pilot study on ten 
parents who did not participate in the main study.  
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After the pilot study the researcher altered the questionnaire based on the feedback and 
limitations identified.  For example, if the option “no” was not appropriate, an option “not 
sure/no idea” was added. If a child had not received the HPV vaccine, the follow-up 
question of completion of the dosage did not apply and the option “not applicable” was 
added.  
 
3.3.5 Data analysis  
 
Data analysis entails categorising, ordering, manipulating and summarising the data 
and describing them in meaningful terms (Brink et al 2006:170).  
 
A statistician analysed the data using the statistical package for social sciences (SPSS) 
version 19. Inferential statistics were used. Inferential analysis of variance (ANOVA) 
was used to test the relationship between knowledge, attitude and behaviour. The 
responses were scored on a 4-point Likert scale and coded consistently with the 
respondents’ responses.  
 
ANOVA is the test that provides a global assessment of the statistical significance in 
more than two independent means (Sullivan 2012:152). One-way ANOVA determined 
whether there was a significant difference in educational level regarding attitudes and 
behaviour towards HPV and the HPV vaccine. The Chi-square was calculated to 
compare knowledge, attitudes and behaviour between males and females.  
 
Percentages for demographic characteristics were calculated. The researcher 
calculated and compared the percentages of parents’ knowledge, attitudes and 
behaviour between the four wards. Relationships, associations and inferences were 
made. Chapter 4 discusses the data analysis and interpretation and results in detail. 
 
3.4 INTERNAL AND EXTERNAL VALIDITY  
 
Validity is the degree to which an instrument measures what it is supposed to measure 
(Polit & Beck 2012:336). Validity refers to the extent to which an empirical measure 
adequately reflects the real meaning of the concept under consideration (De Vos et al 
2011:172). Internal validity concerns the validity of inferences that, given that an 
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empirical relationship exists, it is the independent variable that caused the outcome, not 
something else (Polit & Beck 2012:236). Internal validity implies that the independent 
variable is the one that caused the outcomes. 
 
Knowledge was the independent variable in the study. The parents’ knowledge 
determined whether they would have a positive attitude towards HPV and HPV vaccine 
and their willingness to vaccinate their daughters.  
 
This study indicated a positive relationship and association between knowledge and 
attitude, and that attitude influenced behaviour. The study also found that knowledge 
influenced the parents’ acceptance of the HPV vaccine. 
 
External validity is the extent to which  it  can be inferred that relationships observed in 
a study hold true over variations in people, conditions and settings as well as variations 
in treatment and outcome (Polit & Beck 2012:250). External validity is about the 
generalisability of causal inferences (Polit & Beck 2012:237). This means whether the 
same results will be achieved by a different researcher and whether results could be 
generalised to the community. The findings from the study were generalised to parents 
of adolescent girls in Sefhare. The same results can be obtained by a different 
researcher.   
 
3.5 CONFOUNDING VARIABLES 
 
A confounding variable is a variable that is extraneous to the research question and 
confounds the relationship between the independent and dependent variables (Polit & 
Beck 2012:723). A confounding variable is not important to the research question but 
can affect the relationship between independent and dependent variables. In this study, 
gender was a confounding variable.  
 
Randomisation was used to control the confounding variable. Both male and female 
respondents were sampled randomly. Stratification was also used, which gave the 
researcher the opportunity to study and compare the difference between male and 
female respondents’ knowledge, attitudes and behaviour towards HPV and the HPV 
vaccine. 
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3.6 ETHICAL CONSIDERATIONS 
 
When humans are used as study respondents care must be taken in ensuring that their 
rights are protected (Polit & Beck 2012:166). Accordingly, the researcher obtained 
permission to conduct the study, obtained informed consent from the respondents, and 
observed the ethical principles of beneficence, respect for persons, autonomy and 
justice (Polit & Beck 2012:748). 
 
Permission: The researcher obtained permission to conduct the study from the Ministry 
of Health Research Unit (Botswana) and from the Research and Ethics Committee of 
the Department of Health Studies, University of South Africa (see Annexures A, B and 
C). The ethical clearance certificate number is HSHDC/679/2017. 
 
Beneficence and non–maleficence: The right to protection from discomfort and harm 
is based on the ethical principle of beneficence, which holds that one should do good 
and, above all, do no harm. Beneficence imposes an obligation on researchers to 
minimise harm and maximise benefits. The respondents were assured that their 
participation or information they might provide would not be used against them in any 
way. There were no anticipated negative effects for the respondents, as the study was 
non-experimental.   
 
Justice: The right to fair treatment is based on the ethical principle of justice.  This 
principle holds that each person should be treated fairly and should receive what he or 
she is due or owed (Polit & Beck 2012:172). In this study, the respondents’ selection 
was fair as they were selected for reasons directly related to the problem being studied. 
 
Autonomy: This principle includes the right to self-determination and the right to full 
disclosure. The right to self-determination is based on the ethical principle of respect for 
persons and indicates that people are capable of controlling their own destiny. The 
respondents’ right to self-determination was ensured by explaining the purpose and 
significance of the study to them; obtaining their informed consent; emphasising that 
participation was free and voluntary, and that they had the right to withdraw from the 
study at any time without the risk of penalty or prejudicial treatment (Polit & Beck 
2012:171). When the respondents agreed to participate, they signed the consent form 
and the interview started. Respondent’s responses were recorded on the questionnaire.  
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The respondents were assured of privacy, confidentiality and anonymity. Anonymity 
was assured as no names were written on the questionnaire. The data was treated in 
strictest confidence and kept under lock and key. No one had access to the data.  
 
3.7 CONCLUSION  
 
This chapter discussed the research design and methodology used in the study. The 
researcher selected a quantitative, descriptive cross-sectional design and the 
respondents were parents with adolescent girls aged 9-13 years living in Sefhare, 
Botswana. The chapter briefly described the data collection and analysis, validity, and 
the ethical considerations upheld in the study.  
 
Chapter 4 discusses the data analysis and interpretation and findings. 
 
 
 
 
 
 
 
 
 
. 
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CHAPTER 4 
 
DATA ANALYSIS AND INTERPRETATION AND FINDINGS 
 
4.1 INTRODUCTION 
 
This chapter discusses the data analysis and interpretation, and findings. Data was 
collected by means of face-to-face-interviews using a structured questionnaire. The 
study focused on the respondents’ knowledge, attitudes and behaviour towards HPV 
and the HPV vaccine.  
 
4.2 DATA MANAGEMENT AND ANALYSIS 
 
Data analysis refers to the systematic organisation and synthesis of research data and 
the testing of research hypotheses using those data (Polit & Beck 2012:215). The 
process involves reducing collected data to a manageable size, developing summaries, 
identifying patterns and applying statistical techniques.  
 
Numerical coding was used for the data collected.  For example, in the demographic 
data, 1 was used for ‘male’ and 2 for ‘female’; the four wards were coded as 1, 2, 3, and 
4, respectively. The responses to educational level and marital status were also coded 
individually. Knowledge was measured using an ordinal scale where responses were 
scored as 1 for ‘yes’, 2 for ‘no’ and 3 for ‘no idea’. Attitudes were measured using a 4-
point Likert scale, where 1 indicated ‘strongly disagree’; 2 was ‘disagree’, 3 was ‘agree’ 
and 4 was ‘strongly agree’. An ordinal scale was also used to measure behaviour, 
namely 1 for ‘yes’, 2 for ‘no’ and 3 for ‘not applicable’ or ‘not sure’.   
 
The statistician created a statistical database using the statistical package for social 
sciences (SPSS) version 19.0 software, and entered the data from the questionnaire. 
The variables measured were knowledge, attitudes and behaviour. Inferential statistics 
were used. Inferential analysis of variance (ANOVA) was used to test the relationship 
between knowledge, attitude and behaviour (Sullivan 2012:152). One-way ANOVA 
determined whether there was a significant difference in educational level regarding 
attitudes and behaviour towards HPV and the HPV vaccine. The responses were 
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scored on a 4-point Likert scale and coded consistently with the respondents’ 
responses. The Chi-square was calculated to measure associations and compare 
knowledge, attitudes and behaviour between males and females. Percentages were 
calculated for knowledge, attitudes, and behaviour and compared between wards. 
 
4.3 RESULTS 
 
The results are presented according to the sections on the questionnaire. 
 
4.3.1 Respondents’ demographic data 
 
The demographic data included gender, age, level of education, occupation, and marital 
status. 
 
4.3.1.1 Gender  
 
Of the respondents, 78% (n=78) were females and 22% (n=22) were males.  
 
4.3.1.2 Age  
 
The respondents’ age distribution ranged from 25 to 45 and above. Of the respondents,  
10% (n= 10) were 25-29; 15% (n= 15) were 30-34; 25% (n= 25) were 35-39; 44% 
(n=44) were 40-44, and 6% (n= 6) were 45 and above. 
 
The respondents’ daughters were aged 9 to 13. Of the daughters, 17% (n=17) were 9 
years old; 18% (n=18) were 10; 23% (n=23) were 11; 24% (n=24) were 12, and 18% 
(n=18) were 13 years old.  
 
4.3.1.3 Level of education 
 
Of the respondents, 4% (n=4) had never been to school; 29% (n= 29) had been to 
primary school; 40% (n=40) had passed secondary school, and 27% (n= 27) had a 
tertiary education. 
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4.3.1.4 Occupation 
 
Of the respondents, 49% (n=49) were unemployed; 8% (n=8) self-employed, and 43% 
(n= 43) were employed. 
 
4.3.1.5 Marital status 
 
Of the respondents, 61% (n=61) were single; 28% (n=28) were married; 5% (n=5) were 
divorced, and 6% (n=6) were widowed. 
 
4.3.1.6 Wards  
 
Four wards in the Sefhare village participated in the study, namely Bobirwa (ward 1), 
Maifala (ward 2), Sefhare (ward 3) and Seruleng (ward 4), respectively. Twenty five 
parents from each ward participated in the study. Table 4.1 presents the 
respondents’ demographic data. 
 
Table 4.1 Respondents’ demographic data 
 
  Frequency Percent 
Gender  Male  22 22 
Female  78 78 
Total  100 100 
Age  25-29 years 10 10 
30-34 years 15 15 
35-39 years 25 25 
40-44 years  44 44 
45 and above 6 6 
Total 100 100 
Level of education  Never been to school 4 4 
Primary 29 29 
Secondary 40 40 
Tertiary 27 27 
Total 100 100 
Occupation Unemployed 49 49 
Self-employed 8 8 
Employed 43 43 
Total 100 100 
Marital status Single 61 61 
Married 28 28 
Divorced 5 5 
Widowed 6 6 
Total 100 100 
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4.3.2 Knowledge about HPV 
 
This section discusses the respondents’ knowledge about HPV, HPV infection, cervical 
cancer and the HPV vaccine, and their attitudes and behaviour. 
 
4.3.2.1 Knowledge about HPV infection 
 
Of the respondents, 76% (n=76) had heard about HPV infection from different sources 
namely, from a friend (2%; n=2); a health worker (59%; n=59); the media (13%, n=13), 
and other sources (2%; n=2). In this case ‘other’ referred to information from children.  
 
Regarding whether HPV can be transmitted through sex, 54% (n=54) of the 
respondents answered ‘yes’; 19% (n =19) answered ‘no’, and 27% (n=27) had ‘no idea’ 
or were ‘not sure’. 
 
Regarding whether HPV infection can cause cervical cancer, 68% (n=68) said ‘yes’; 6% 
(n=6) said ‘no’, and 26% (n=26) had ‘no idea’. Regarding whether a condom partially 
protects one from contracting HPV infection, 54% (n=54) said ‘yes’ and 20% (n=20) said 
‘no’. Of the respondents, 71% (n=71) said ‘yes’; 3% (n=3) said ’no’, and 26% (n=26) 
had ‘no idea’ or were ‘not sure’ whether HPV could be prevented. Of the respondents, 
72% (n=72) said ‘yes’; 2% (n=2) said ‘no’, and 26% (n=26) had ‘no idea’ whether 
multiple sex partners increase the risk of acquiring HPV. Figure 4.1 depicts the 
respondents’ knowledge about HPV infection. 
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Figure 4.1   Respondents’ knowledge about HPV infection 
 
4.3.2.2 Knowledge about cervical cancer 
 
Of the respondents, 98% (n=98) had heard about cervical cancer from various sources, 
namely a friend (10%; n=10), a health worker (76%; n=76), and the media (12%; n=12). 
All the respondents who had heard about cervical cancer believed that it is a serious 
disease and can cause death. Of the respondents, 91% (n=91) knew that cervical 
cancer is caused by HPV and 94% (n=94) knew that it can be prevented. Of the 
respondents, 76% (n=76) knew that the Pap smear is used to detect cervical cancer; 
18% (n=18) said ‘no’, and 6% (n=6) had ‘no idea’.  
 
Of the respondents, 54% (n=54) knew that Pap smear is done 2-3 years, 39% (n=39) 
said ‘no’ and 7% (n=7) had no idea. Of the respondents, 93% (n=93) knew that cervical 
cancer can be treated if diagnosed early. Regarding whether cervical cancer can 
threaten the relationship between partners, 88% (n=88) said ‘yes’, 11% (n=11) said ‘no’ 
and 1% (n=1) had no idea. Of the respondents, 68% (n=68) knew anyone who has/had 
cervical cancer, and 32% (n=32) said ‘no’. Figure 4.2 presents the respondents’ 
knowledge about cervical cancer. 
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Figure 4.2   Respondents’ knowledge about cervical cancer 
 
4.3.2.3 Knowledge about the HPV vaccine 
 
Of the respondents, 80% (n=80) had heard about the HPV vaccine from various 
sources, namely 12% (n=12) had heard from a friend, 59% (n=59) from a health worker, 
and 16% (n=16) from the media. Of the respondents, 80% (n=80) knew that the HPV 
vaccine is used to prevent cervical cancer; 30% (n=30) knew the dosage intervals of the 
vaccine while 70% (n=70) did not, and 71% (n=71) said that they had been told about 
the benefits of a girl being vaccinated.  
 
Of the respondents, 37% (n=37) knew the adverse effects of the vaccine while 60% 
(n=60) did not. Finally, 83% (n=83) knew that the HPV vaccine is offered free by the 
government. Figure 4.3 depicts the respondents’ knowledge about the HPV vaccine. 
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Figure 4.3   Respondents’ knowledge about the HPV vaccine 
 
4.3.2.4 Attitude towards the HPV vaccine 
 
Of the respondents, 75% (n=75) strongly agreed that they feel confident in taking their 
daughters for HPV vaccination, while 25% (n=25) agreed. Of the respondents, 78% 
(n=78) strongly agreed that there are health benefits for getting the HPV vaccine while 
22% (n=22) agreed. Of the respondents, 69% (n=69) strongly agreed that the HPV 
vaccine is effective in preventing cervical cancer and 31% (n=31) agreed. Of the 
respondents, 40% (n=40) strongly agreed that they have no problem in telling their 
children if they have cervical cancer and 38% (n=38) agreed. Of the respondents, 43% 
(n-43) strongly agreed; 36% (n=36) agree while 18% (n=18) disagreed that the HPV 
vaccine prevents HPV and STDs (sexually-transmitted diseases). Of the respondents, 
73% (n=73) strongly disagreed that the HPV vaccine can cause infertility and 9% (n=9) 
agreed.  
 
Of the respondents, 55% (n=55) strongly agreed that the vaccine is best administered 
before sexual intercourse and 32% (n=32) agreed. With regard to the doses, 52% 
(n=52) strongly agreed and 46% (n=46) agreed. Of the respondents, 31% (n=31) 
agreed, 38% (n=38) disagreed and 2% (n=2) strongly disagreed that the HPV vaccine 
information was clearly explained. Of the respondents, 29% (n=29) strongly agreed that 
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the HPV vaccine was clearly publicised or disseminated. Figure 4.4 illustrates the 
respondents’ attitudes towards the HPV vaccine. 
 
 
Figure 4.4   Respondents’ attitudes towards the HPV vaccine 
 
One-way ANOVA was used to test the relationship between the respondents’ level of 
education and attitudes towards the HPV vaccine. To evaluate the relationship, p-
value/significance was calculated, such that if it is below 0.1, the conclusion is that there 
is relationship. A significance of 0.074 was obtained for the question ‘HPV is effective in 
preventing cervical cancer’. A significance of 0.036 was seen in the question ‘the girl 
should get three doses of HPV vaccine’. The question ‘it is important to complete all 3 
doses’ obtained a significance of 0.008. A slight significance of 0.124 was found in the 
question ‘HPV vaccine can cause infertility’. The results showed a slight significance of 
0.139 in the question ‘there are health benefits for getting HPV vaccine’. Table 4.2 
shows the one-way ANOVA results. 
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Table 4.2 One-way ANOVA for respondents’ education vs attitude 
 
Parameter 
Mean 
square 
Df F Sig 
1. I am able to make decisions that affect 
my household 
.300 3 1.273 .288 
2. I feel confident taking my daughter for 
HPV vaccination 
.155 3 .813 .490 
3. There are health benefits for getting the 
HPV vaccine 
.317 3 1.877 .139 
4. HPV vaccine is effective in preventing 
cervical cancer 
.495 3 2.388 .074 
5. HPV vaccine prevents HPV and STIs .996 3 1.440 .236 
6. HPV vaccine can cause infertility .942 3 1.968 .124 
7. It is best to administer HPV .367 3 .581 .629 
8. The girl should get 3 doses of HPV 
vaccine 
.753 3 2.963 .036 
9. It is important to complete all 3 doses 1.127 3 4.224 .008 
10.  HPV vaccine information was clearly 
explained 
1.184 3 1.629 .188 
11. HPV information was clearly publicised .608 3 1.629 .571 
 
4.3.2.5 Behaviour towards HPV vaccine 
 
Of the respondents, 53% (n=53) had immunised their daughters and 39% (n=39) had 
not, while 8% (n=8) were not sure whether the child had been vaccinated or not. All the 
respondents who did not immunise their daughters intended to take their daughters for 
vaccination, including those who were not sure about the immunisation status of their 
children. 
 
The study found that 21% (n=21) of the respondents’ daughters had completed all the 
vaccine doses; 25% (n=25) had not, and 10% (n=10) of the respondents were not sure.  
 
All the respondents whose daughters had not completed the doses said they would take 
their daughters for the remaining doses. Of the respondents, 91% (n=91) said they 
would encourage other parents to take their daughters for immunisation. Furthermore, 
98% (n=98%) had no cultural or spiritual beliefs that prevented them having their 
daughters vaccinated. Figure 4.5 illustrates the respondents’ behaviour towards the 
HPV vaccine. 
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Figure 4.5   Respondents’ behaviour towards the HPV vaccine 
 
Regarding the HPV vaccine uptake, of the respondents’ daughters, 53% (n=53) had 
been vaccinated; 39% (n=39) had not, and 8% (n=8) were not certain.  Of the girls who 
had been vaccinated: 2 were 9 years old; 3 were 10 years old; 8 were 11 years old; 23 
were 12 years old, and 17 were 13 years old. Table 4.3 lists the age and immunisation 
status of the girls. 
 
Table 4.3 Age of child and immunisation status (HPV vaccine uptake) 
 
Age of child Yes No Not sure Total 
9 years 2 13 2 17 
10 years 3 14 1 18 
11 years 8 10 5 23 
12 years 23 1 0 24 
13 years  17  1 0 18 
Total 53 39 8 100 
 
One-way ANOVA was used to test the relationship between the respondents’ level of 
education and behaviour towards the HPV vaccine. To evaluate the relationship 
between their level of education and attitudes, p-value/significance was calculated, such 
that if it is below 0.1 the conclusion is that there is a relationship. The results showed a 
significance of 0.381 for the question whether the child had been immunised. A 
significance of 0.491 was obtained for the question whether parents would encourage 
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other parents to take their daughters for immunisation. A significance of 0.140 was also 
obtained for the question whether there were cultural or religious beliefs that hindered 
HPV vaccination of their daughters. Table 4.4 shows the ANOVA results of 
respondents’ level of education and behaviour.   
 
Table 4.4 Respondents’ level of education and behaviour towards HPV vaccine 
 
Parameter 
Mean 
square 
Df F Sig 
Is your child immunised? .425 3 1.035 .381 
Would you encourage other parents to take 
their daughters for vaccination? 
.008 3 .811 .491 
Are there any cultural or religious beliefs that 
hinder your daughter from taking the HPV 
vaccine? 
.036 3 1.869 .140 
 
The results indicated that of the respondents, 65.1% (n=65) knew about HPV infection; 
86% (n=86) knew about cervical cancer, and 64.5% (n=64) knew about the HPV 
vaccine. Of the respondents, 81.5% (n=81) had a positive attitude towards the HPV 
vaccine and 62.4% (n=62) showed positive behaviour towards the HPV vaccine.  Table 
4.5 indicates the overall results of the respondents’ knowledge, attitudes and behaviour 
towards HPV/HPV vaccine. 
 
Table 4.5 Respondents’ overall knowledge, attitude and behaviour towards 
HPV/HPV vaccine  
 
Variable Percentage 
Knowledge about HPV infection 65.1 
Knowledge about cervical cancer 86.0 
Knowledge about HPV vaccine 64.5 
Attitude towards HPV vaccine 81.5 
Behaviour towards HPV vaccine 62.4 
 
4.3.3 Ward results 
 
Parents from four wards in Sefhare village took part in the study, namely Bobirwa (ward 
1), Maifala (ward 2), Sefhare (ward 3) and Seruleng (ward 4). It should be noted that 
there is a ward in Sefhare village which is called Sefhare. The parents from the four 
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wards were compared to determine their level knowledge, attitudes and behaviour 
towards HPV/HPV vaccine. The following sections discuss the results. 
 
4.3.3.1 Ward 1 (Bobirwa) 
 
The results show that of the 25 respondents from ward 1 (Bobirwa), 21 had a high 
knowledge of HPV infection; 13 knew that HPV infection can be transmitted through 
sex; 19 knew that HPV infection can be prevented, and 20 knew that multiple partners 
increase the risk of acquiring HPV. Of the respondents, 24 had heard about cervical 
cancer; all (25) believed that cervical cancer is a serious disease and can cause death; 
24 knew that cervical cancer is caused by HPV and all (25) knew that cervical cancer 
can be prevented. Of the respondents, 23 knew that cervical cancer can be treated if 
diagnosed early and 18 knew someone who had cervical cancer.  
 
Of the respondents, 23 had heard about the HPV vaccine; 19 knew that the vaccine is 
used to prevent cervical cancer; 9 knew the dosage intervals for the HPV vaccine, and 
17 knew of the benefits of girls being vaccinated.  
 
The respondents from ward 1 showed a positive attitude; 19 strongly agreed and 6 
agreed that they felt confident in taking their daughters for vaccination.  
 
Of the respondents, 20 strongly agreed and 5 agreed that there are health benefits of 
getting HPV vaccine.  
 
Of the respondents, 14 strongly agreed and 8 agreed that it is best to administer the 
HPV vaccine before sexual initiation, and 25 agreed that it is important to complete all 
the doses. Of the respondents, 11 disagreed and 1 strongly disagreed that the HPV 
information was clearly explained. 
 
Of the respondents, 12 girls had been vaccinated in ward 1 and 4 had completed the 
dosages. All the parents whose daughters had not been immunised intended to 
immunise them, including those whose daughters did not complete the doses. 
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4.3.3.2 Ward 2 (Maifala) 
 
Of the respondents in ward 2 (Maifala), 18 were aware and knew about HPV infection, 
and 14 knew that HPV infection can be transmitted through sex.   
 
Of the respondents, 17 knew that HPV causes cervical cancer; 18 knew that it can be 
prevented by vaccination with the HPV vaccine, and 17 knew that multiple sex partners 
can put one at risk of contracting the HPV infection.  
 
Of the respondents, 25 had heard about cervical cancer and knew that it is a serious 
disease; 24 knew that cervical cancer can cause death; 22 knew that cervical cancer is 
caused by HPV; 24 knew that cervical cancer can be prevented, and 24 knew that 
cervical cancer can be treated if diagnosed early.  
 
Of the respondents, 20 had heard about the HPV vaccine; 18 knew that the HPV 
vaccine is used to cervical cancer, and 8 knew the dosage interval for the HPV vaccine. 
Of the respondents, 19 said that they had been told about the benefits of vaccinating 
their daughters, and 11 said that the adverse effects of the HPV vaccine had been 
explained to them. 
 
The respondents showed a positive attitude towards the HPV vaccine and 19 strongly 
agreed and 6 agreed that they felt confident to take their daughters for vaccination. Of 
the respondents, 25 felt that there are health benefits for getting the HPV vaccine; 18 
strongly agreed and 7 agreed that the HPV vaccine is effective in preventing cervical 
cancer, and 12 strongly agreed and 10 agreed that is best to administer the HPV 
vaccine before sexual initiation.  
 
Of the respondents, 12 strongly agreed and 13 agreed that it is important to complete all 
the doses. Regarding explanation of the HPV vaccine, 7 agreed that it was clearly 
explained to them, while 8 strongly disagreed and 10 disagreed. 
 
Of the respondents’ daughters, 15 had been vaccinated and 6 had completed the 
doses. The respondents whose daughters had not yet been vaccinated expressed their 
willingness to have them vaccinated. All the respondents would encourage other 
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parents to take their daughters for vaccination. There were no cultural or religious 
beliefs that hindered the respondents from vaccinating their daughters.  
 
4.3.3.3 Ward 3 (Sefhare) 
 
Of the respondents in ward 3 (Sefhare), 20 were aware of HPV infection; 14 knew that it 
causes cervical cancer; 17 knew that HPV can be prevented, and 18 knew that multiple 
sex partners put one at risk of contracting HPV.  
 
Of the respondents, 24 were aware of cervical cancer; 24 knew that cervical cancer can 
be prevented, and 23 said cervical cancer can be treated if diagnosed early.  
 
Of the respondents, 19 knew or had seen someone with cervical cancer; 22 had heard 
about the HPV vaccine, and 24 knew that the HPV vaccine is used to prevent cervical 
cancer. Of the respondents, 18 did not know about dosage intervals and 15 did not 
know the adverse effects of the HPV vaccine. 
 
The respondents of ward 3 also showed a positive attitude towards the HPV vaccine. Of 
the respondents, 16 strongly agreed and 6 agreed that they felt confident in taking their 
daughters for vaccination; 17 strongly agreed and 8 agreed that there are health 
benefits for a girl to be vaccinated; 14 strongly agreed and 11 agreed that HPV is 
effective in preventing cervical cancer. Of the respondents, 13 strongly agreed and 12 
agreed that girls should complete all the doses.  
 
Of the respondents, 12 had vaccinated their daughters, but 6 of them did not complete 
the doses. Those who did not vaccinate their daughters were willing and intended to 
immunise them. There were no cultural or religious beliefs that hindered the 
respondents from vaccinating their daughters.  
 
4.3.3.4 Ward 4 (Seruleng)   
 
The respondents in ward 4 (Seruleng) showed a good level of awareness and 
knowledge about HPV infection. Of the respondents, 17 had heard about HPV; 16 knew 
that HPV causes cervical cancer; 17 knew that HPV can be prevented, and 17 knew 
that multiple sex partners put one at risk of contracting HPV.  
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There was a high level of awareness and knowledge about cervical cancer. Of the 
respondents, 25 had heard about cervical cancer; 21 knew that cervical cancer can be 
prevented; 23 knew that when diagnosed early it can be prevented; 16 knew that a Pap 
smear is used to detect cervical cancer; 14 knew the time interval for doing a Pap 
smear, and 17 knew or had seen someone who had cervical cancer. 
 
A positive attitude was also seen in ward 4. Of the respondents, 21 strongly agreed and 
4 agreed that they feel confident to take their daughters for vaccination; 23 strongly 
agreed and 2 agreed that there are health benefits for girls to be vaccinated; 22 strongly 
agreed and 3 agreed that the HPV vaccine is effective in preventing cervical cancer. 
Finally, of the respondents, 16 strongly agreed, 7 agreed and 2 disagreed that it is 
important for girls to complete all the doses.  
 
Of the respondents, 14 had vaccinated their daughters but 7 did not complete the 
doses. All respondents who had not vaccinated their daughters were willing to have 
them immunised. Those with daughters that had not completed the doses also intended 
to have them complete the dosages. There are no cultural or religious beliefs that hinder 
vaccination of daughters. 
 
The respondents’ knowledge of the HPV vaccine from the four wards was 
calculated. Table 4.6 summarises the percentage distribution. 
  
Table 4.6 Percentage distribution of respondents’ knowledge of HPV in 
the wards 
 
Factor Ward 1 Ward 2 Ward 3 Ward 4 Total 
Knowledge about HPV infection 26.2 24.8 25.1 23.9 100.0 
Knowledge about cervical cancer 24.9 26.1 24.4 24.6 100.0 
Knowledge about HPV vaccine 26.1 25.3 27.4 21.2 100.0 
 
Table 4.7 lists the respondents’ attitudes scores from the four wards. 
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Table 4.7 Percentage distribution of respondents’ attitude towards the HPV 
vaccine in the wards 
 
Parameter Ward 1 Ward 2 Ward 3 Ward 4 Total 
1. I am able to make decisions 
that affect my household 
     
 Agree 23.7 26.3 18.4 31.6 100.0 
 Strongly agree 25.8 24.2 29.0 21.0 100.0 
2. I feel confident in taking my 
daughter for HPV vaccination 
     
 Agree 24.0 24.0 36.0 16.0 100.0 
 Strongly agree 25.3 25.3 21.3 28.0 100.0 
3. There are health benefits for 
getting HPV vaccine 
     
 Agree 22.7 31.8 36.4 9.1 100.0 
 Strongly agree 25.6 23.1 21.8 29.5 100.0 
4. HPV vaccine is effective in 
preventing cervical cancer 
     
 Agree 32.3 22.6 35.5 9.7 100.0 
 Strongly agree 21.7 26.1 20.3 31.9 100.0 
5. I have no problem telling my 
child if I have cervical cancer 
     
6. HPV vaccine prevents HPV and 
STIs 
    1 
 Strongly disagree 66.7 0.0 33.3 0.0 100.0 
 Disagree 38.9 11.1 22.2 27.8 100.0 
 Agree 27.8 30.6 33.3 8.3 100.0 
 Strongly agree 14.0 27.9 18.6 39.5 100.0 
7. HPV vaccine can cause 
infertility 
     
 Strongly disagree 20.0 20.0 40.0 20.0 100.0 
 Disagree 24.7 27.4 26.0 21.9 100.0 
 Agree 22.2 22.2 22.2 33.3 100.0 
 Strongly agree 37.5 12.5 0.0 50.0 100.0 
8. It is best to administer HPV 
vaccine before sexual initiation 
    1 
 Strongly disagree 0.0 66.7 0.0 33.3 100.0 
 Disagree 30.0 10.0 20.0 40.0 100.0 
 Agree 25.0 31.3 28.1 15.6 100.0 
 Strongly agree 25.5 21.8 25.5 27.3 100.0 
9. The girl should get 3 doses of 
HPV vaccine 
     
 Disagree 0.0 0.0 0.0 100.0 100.0 
 Agree 25.9 31.5 25.9 16.7 100.0 
 Strongly agree 24.4 17.8 24.4 33.3 100.0 
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Parameter Ward 1 Ward 2 Ward 3 Ward 4 Total 
10. It is important to complete all 3 
doses 
     
 Disagree 0.0 0.0 0.0 100 100.0 
 Agree 30.4 28.3 26.1 15.2 100.0 
 Strongly agree 21.2 23.1 25.0 30.8 100.0 
11. HPV vaccine information was 
clearly explained 
     
 Strongly disagree 50.0 0.0 50.0 0.0 100.0 
 Disagree 28.9 26.3 23.7 21.1 100.0 
 Agree 16.1 22.6 32.3 29.0 100.0 
 Strongly agree 27.6 27.6 17.2 27.6 100.0 
12. HPV information was clearly 
publicised 
     
 Strongly disagree 25.0 25.0 0.0 50.0 100.0 
 Disagree 34.3 25.7 17.1 22.9 100.0 
 Agree 13.0 17.4 47.8 21.7 100.0 
 Strongly agree 23.7 28.9 21.1 26.3 100.0 
 
Table 4.8 shows the respondents’ behaviour from the four wards. 
 
Table 4.8 Percentage distribution of respondents’ behaviour towards the HPV 
vaccine  
 
Factor Ward 1 Ward 2 Ward 3 Ward 4 Total 
Immunised child 22.6 28.3 22.6 26.4 100.0 
Child who completed dosages 19.0 28.6 23.8 28.6 100.0 
Plans to immunise child 22.7 22.7 29.5 25.0 100.0 
Encourage other parents to vaccinate 
their daughters 
25.3 25.3 24.2 25.3 100.0 
 
4.4 COMPARISON BETWEEN MALE AND FEMALE  
 
The Chi-square test was used to compare knowledge of HPV between males and 
females. The results below are based on Pearson’s chi-square. To compare the 
knowledge r-value was observed. Pearsons’ r-value can be descriptive or inferential. 
Descriptively, the correlation coefficient summarises the magnitude and direction of a 
relationship between two variables (Polit & Beck 2012:421). If the computed r-value is 
high than the tabled r at 0.1 significance, the null hypothesis is rejected. The null 
hypothesis is that there is no relation between gender and knowledge/attitude/ 
behaviour.  
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The comparison between males and females found the following results obtained when 
comparing males and females. Knowledge about HPV infection: an r-value of 0.945 with 
df =1 was obtained for the question ‘have you heard of HPV infection’, which is lower 
than the tabled r-value 0.98769. For the question ‘can HPV be transmitted through sex’ 
an r- value of 0.671 was obtained with df=2. This is lower than the tabled 0.90000. The 
question ‘does HPV infection cause cervical cancer’ obtained r-value of 1.146 with df = 
2. This is higher than the tabled 0.90000. An r-value of 1.245 with df=2, which is higher 
than 0.90000, was obtained for the question ‘can HPV infection be prevented’. 
Questions 2,4,6,7 and 8 obtained r-values higher than the tabled r-values. Table 4.9 
presents the chi-square results of knowledge between the males and females. 
 
Table 4.9 Knowledge about HPV infection between males and females 
 
Variable Males Females Df Value 
Have you heard about HPV infection 19.7 80.3 1 .945 
Can HPV infection be transmitted through sex 22.2 77.8 2 .671 
Dies HPV infection cause cervical cancer 19.1 80.9 2 1.146 
Does using a condom partially protect one from 
contracting HPV infection 
20.4 79.6 2 .497 
Anyone who has sex could contract HPV infection 24.6 75.4 2 2.098 
Can HPV infection be prevented 21.1 78.9 2 1.245 
Do multiple sex partners increase the risk of 
acquiring HPV 
19.4 80.6 2 1.555 
 
Knowledge about cervical cancer was also compared between male and female 
respondents. The results showed an r-value of 0.932 with df=1 for the question ‘have 
you had about cervical’.  The question ‘is cervical cancer a serious disease’ obtained an 
r-value of 0.576 with df=1 which was less than the tabled 0.98769. An r-value of 2.790 
with df=2 was obtained for ‘cervical cancer is caused by HPV’. This was more than the 
tabled 0.90000. The question ‘cervical cancer can be prevented’ obtained an r-value of 
1.800 with df=1, which was higher than the tabled 0.90000. Questions 10, 12,13,16,17 
and 19 obtained an r-value below the tabled r-values.  
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Table 4.10 Knowledge of cervical cancer between males and females 
 
Variable Males Females Df Value 
Have you heard about cervical cancer 21.4 78.6 1 .932 
Is cervical cancer a serious disease 22.4 77.6 1 .576 
Cervical cancer can cause death 22.2 77.8 1 .285 
Cervical cancer is caused by HPV 24.2 75.8 2 2.790 
Cervical cancer can be prevented 23.4 76.6 1 1.80 
Pap smear is used to detect cervical cancer 21.1 78.9 2 .489 
Pap smear is done every 2-3 years 20.4 79.6 2 .628 
Cervical cancer can be treated if diagnosed early 20.4 79.6 1 1.908 
Cervical cancer can threaten the relationship 
between partners 
22.7 77.3 2 .403 
Do you know anyone that has/had cervical 
cancer 
19.1 80.9 1 1.029 
 
A comparison of knowledge about HPV vaccine was made between male and female 
respondents. The results show an r-value of 0.291 with df =2 for the question ‘have you 
had about HPV vaccine’, which was less than the tabled 0.90000. An r-value of 1.838 
with df=2 was obtained for question ‘HPV vaccine is used to prevent cervical cancer’, 
which was higher than the tabled 0.90000. The question ‘do you know the dosage 
interval of the vaccine’ obtained an r-value of 0.710 with df=1, which was less than the 
tabled 0.98769. The question ‘have adverse effects been explained to you’ obtained an 
r-value of 0.911 with df =2, which was higher than the tabled 0.90000. Questions 22, 23, 
25, 26 and 27 obtained an r-value above the tabled r-values.  
 
Table 4.11  Knowledge about HPV vaccine between males and females 
 
Variable Males Females Df Value 
Have you heard about HPV vaccine 22.1 77.9 2 .291 
HPV vaccine is used to prevent cervical cancer 23.8 76.2 2 1.838 
Do you know the dosage intervals of HPV 
vaccine 
16.7 83.3 1 .710 
Have you been told about the benefits of a girl 
being vaccinated 
26.8 73.2 2 3.442 
Have the adverse effect been explained to you 21.6 78.4 2 .911 
Do you know that the government offers HPV 
vaccine free 
25.3 74.5 2 3.146 
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A comparison of the male and female respondents’ attitudes towards the HPV vaccine 
revealed an r-value of 0.699 with df=1. This was lower than the tabled 0.98769. An r-
value of 0.240 with df=1was obtained for the question ‘there are health benefits for 
getting HPV vaccine’, which was lower than the tabled 0.98769. Questions 2, 3, 4, 7, 9, 
and 10 obtained r-values below the tabled r-values. The question ‘HPV vaccine is 
effective in preventing cervical cancer’ obtained an r-value of 0.183 with df=1, which 
was lower than the tabled 0.98769. An r-value of 1.515 with df=3 was obtained for the 
question ‘it is important to administer HPV vaccine before sexual initiation’, which was 
higher than the tabled 0.8054. An r-value of 0.285 with df=2 was obtained for the 
question ‘the girl should get three doses of HPV vaccine’, which was lower than the 
tabled 0.90000. The question ‘HPV vaccine information was clearly explained’ obtained 
an r-value of 2.586 with df=3, which was higher than the tabled 0.8054. 
 
The male and female respondents’ behaviour towards the HPV vaccine was compared. 
Questions 1-4 obtained an r-value above the tabled r-values. An r-value of 1.449 with 
df=2 was obtained for the question ‘is your child immunised’, which was higher than the 
tabled 0.90000. An r-value of 3.581 with df=1was obtained for the question ‘would you 
encourage other parents to take their daughters for immunisation’ which was higher 
than the tabled 0.98769. The question ‘are there any cultural or religious beliefs that 
hinder your daughter from taking the vaccine’ obtained an r-value of 0.576 with df=1, 
which was lower than the tabled 0.98769.  Table 4.12 summarises the behaviour of the 
males and females towards the HPV vaccine. 
 
Table 4.12 Behaviour towards HPV vaccine between males and females 
 
Variable Males Females Df Value 
Is your child immunised 18.9 881.1 2 1.449 
Did she complete all the dosages 23.8 76.2 3 .819 
Do you have plans to immunise your child 27.3 72.7 1 1.273 
Would you encourage other parents to take their 
daughters for vaccination 
21.2 78.8 1 3.581 
Are there any cultural or religious beliefs that 
hinder your child from taking HPV vaccine 
22.4 77.6 1 .576 
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4.5 CONCLUSION 
 
This chapter discussed the data analysis and interpretation, and the results. The 
findings were also compared between the four wards and between male and female 
respondents.   
 
Chapter 5 briefly discusses the findings, limitations and contribution of the study, and 
makes recommendations for practice and further research. 
 
 
 
 
  
  
55 
CHAPTER 5 
 
FINDINGS, LIMITATIONS AND RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
This chapter summarises the findings, briefly discusses the limitations and contribution 
of the study and makes recommendations for practice and further research.  
 
5.2 PURPOSE OF THE STUDY 
 
The purpose of the study was to determine the knowledge, attitude and behaviour of 
parents towards HPV and the HPV vaccine in preventing cervical cancer in girls aged 9 
to 13 years in Sefhare, Botswana. The study evaluated the uptake of the HPV vaccine 
and implementation of prevention strategy. 
 
In order to achieve the purpose, the objectives of the study were to: 
 
 Determine the level of knowledge of parents of adolescent girls between the 
ages of 9 to 13 years regarding HPV and HPV vaccine. 
 Assess the attitudes of parents with adolescent girls aged 9 to 13 years towards 
HPV and the HPV vaccine and their willingness to take their daughters for 
vaccination. 
 Determine parents’ behaviour in uptake of the HPV vaccine. 
 Make recommendations based on the findings. 
 
5.3 FINDINGS 
 
The first objective was to determine the respondents’ level of knowledge of HPV/HPV 
vaccine. The findings indicate that, that was achieved as shown by parents’ knowledge 
about HPV infection, cervical cancer and HPV vaccine. Awareness was raised in those 
who did not HPV/HPV vaccine. Knowledge gaps were identified and respondents given 
the necessary education.  
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5.3.1 Knowledge about HPV infection 
 
The study found that 76% had heard about HPV; 65.1% had knowledge about HPV 
infection, and 68% knew that HPV causes cervical cancer. Source of information was 
59% health workers while 13% heard form media. Thus only a small percentage of 
respondents were not aware of HPV infection. Lack of knowledge of HVP infection 
could lead to the spread of HPV and leave young girls at risk of contracting HPV 
infection. 
 
Most of the respondents (71%) knew that HPV can be prevented and were aware that 
having multiple sex partners put one at risk of contracting HPV infection thus exposing 
one to cervical cancer. 61 % of the respondents knew that anyone who has had sex 
could contract the HPV infection. This is also shown by respondents’ willingness to 
vaccinate and complete the dosages for their daughters. 
 
The medium level of awareness and knowledge observed implies that the respondents 
and parents are more likely to comply with the HPV prevention strategy as they are 
aware of the HPV infection. The awareness and knowledge about HPV infection could 
be attributed to the work done by the Ministry of Health, health workers and media 
sensitisation about HPV and cervical cancer. 
 
The results in this study complement those of Milimo et al (2015) conducted in Zambia. 
Milimo et al’s (2015) study also found medium levels of awareness as shown by 64% of 
respondents who had heard about HPV and 69% stated that HPV causes cervical 
cancer.  
 
The study by Ayssi et al (2012) in Cameroon shows higher results in some aspects of 
knowledge regarding HPV infection. The study by Ayissi et al (2012) showed that 82.3 
% of respondents knew that everyone can contact the HPV infection and 75.9% were 
aware that HPV vaccine prevents HPV. Respondents in Ayissi et al study were 
knowledgeable and recommended that their daughters be vaccinated which indicated a 
positive relationship between knowledge and attitude. More likely, the reason why the 
respondents in the Ayissi et al’s (2012) study displayed better knowledge that those in 
this study could be due to the much higher information dissemination (education) on 
HPV infection. 
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In contrast, the results of the study done by Yu et al in China (2016) showed that 
58.69% of the respondents had low knowledge while 26.56 % had high knowledge. 
They found poor awareness and knowledge, and low acceptability of HPV and HPV 
vaccine.  Kornfeld et al (2013) in USA found low levels of awareness and knowledge but 
that despite these, there was a positive attitude and behaviour towards HPV vaccine. 
The difference in the findings of this study and that of Yu et al could be due to 
insufficient provision of information in the case of China. 
 
5.3.2 Knowledge about cervical cancer 
 
There was high awareness and knowledge of cervical cancer.  Of the respondents, 98% 
knew that cervical cancer is a serious disease and can pose a threat to the health of 
their daughters; 99% knew that cervical cancer can cause death; 91% knew that 
cervical cancer is caused by HPV, and 94% knew that it is preventable. 93% know that 
cervical cancer can be treated if diagnosed early; 76% knew that a Pap smear is used 
for cervical cancer detection; 53% knew the interval period for doing Pap smears, and 
68% knew or had seen someone with cervical cancer. These factors contributed to 
respondents’ positive attitude towards HPV vaccine.  
 
The overall results show that 86% of the respondents are knowledgeable about cervical 
cancer, which indicates a high level of knowledge about cervical cancer. This implies 
that when parents are knowledgeable about cervical cancer, its seriousness and the 
threat it poses, they are most likely to comply with the HPV vaccine prevention strategy 
in order to prevent the disease. Ministry of Health, health workers and media have 
contributed to high awareness and knowledge about cervical cancer. Media, both 
television and radio sensitised the public about cervical cancer and advised early 
screening. Health workers also hold health talks in the communities they work in. 
 
Ayissi et al (2015) in Cameroon also found high levels of awareness in cervical cancer 
as, 82.3% of respondents knew that certain genotypes of HPV cause cervical cancer 
and 75.6% knew that abnormal Pap test could be a sign of HPV infection. The high 
levels of awareness resulted in respondents recommending HPV vaccine as 45.6% 
strongly recommended and 33.1% recommended. The findings in the study by Ayissi et 
al (2015) indicate a positive attitude and behaviour.  
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Another study which showed knowledge about cervical cancer was conducted by 
Hussain et al in India (2014). It indicated that of the respondents, 69% of females and 
31% of males knew about cervical cancer.  
 
A contrary study which showed low knowledge about cervical cancer was done in 
France by Haesebaert et al (2012). In that study, 16.9% of respondents knew the 
causes of cervical cancer. The difference in the findings between the Haesebaert et al’s 
(2012) study and this study could again be due to the intensity of information provision 
by the health workers and media on cervical cancer. 
 
5.3.3 Knowledge about the HPV vaccine 
 
The study found a high awareness and knowledge of the HPV vaccine. Of the 
respondents, 86% had heard of the HPV vaccine and 80% knew that it prevents cervical 
cancer. However, only 30% knew about the dosage intervals for the vaccine and 37% 
knew the adverse effects. The results indicate an average of 64.5% knowledge about 
the HPV vaccine, which is a medium level. Lower levels of knowledge were seen in 
dosage interval of the vaccine and adverse effects. Little knowledge of dosage intervals 
could lead to girls missing doses when they are due and/or incomplete doses. This 
could lead to reducing the government initiative of the prevention strategy against 
cervical cancer. Although the respondents did not know much about the vaccine 
dosages and adverse effects, they still believed that it is important for their daughters to 
be vaccinated. The respondents also knew that it is important for the vaccine to be 
given to daughters before sexual debut. 
 
A study by Haesebaert et al (2012) in France revealed a similar result of a high 
awareness level (76.2%) of HPV vaccine. Ayissi et al (2012) in Cameroon also 
demonstrated high awareness results as evidenced by 75.9% being aware that HPV 
vaccine prevents cervical cancer. 
 
In contrast, Hanley et al (2012) in Japan observed slightly lower levels of knowledge 
regarding HPV vaccine in the study, where 52.5% of mothers had heard about HPV 
vaccine. Kornfeld et al (2013) also observed slightly lower awareness (52.7%) of HPV 
vaccine. The lower levels of awareness and knowledge of HPV vaccine could be 
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because the respondents did not receive sufficient information (education) about HPV 
vaccine.  However, despite low levels of awareness, most respondents showed a 
positive attitude to HPV vaccine as evidenced by their willingness to vaccinate their 
daughters. 
 
5.3.4 Attitude towards the HPV vaccine 
 
The second objective was to assess the respondents’ attitudes towards the HPV 
vaccine. The study found a generally positive attitude towards the HPV vaccine. Of the 
respondents, 78% strongly agreed and 22% agreed that there are health benefits for 
getting HPV vaccine; 69% strongly agreed while 31% agreed that HPV vaccine is 
effective in preventing cervical cancer; 73% disagreed and 10% strongly disagreed 
while 8% strongly agreed and 9% agreed that HPV can cause infertility. Of the 
respondents, 45% strongly agreed, 54% agreed and 1% disagreed that a girl should 
take all 3 doses. Of the respondents, 52% strongly agreed, 46% agreed and only 2% 
disagreed that it is important to complete all 3 doses. Finally, of the respondents, 29% 
strongly agreed, 31% agreed, 38% disagreed and 2% strongly disagreed that HPV 
vaccine information was clearly explained.   
 
The findings in this study demonstrate positive attitudes of parents towards HPV 
vaccine. This confirms what was alluded to by Ramogol-Masire (2014), that HPV 
vaccine was highly accepted if it became widely available. The parents’ positive attitude 
towards HPV vaccine resulted in a positive behaviour as evidenced by parents’ 
willingness to vaccinate their daughters. This showed a positive relationship between 
attitudes and behaviour. 
 
The findings in this study affirm the factors or attributes of the Health Belief Model of 
perceived benefits and perceived vulnerability. The respondents perceived that there 
are health benefits of getting HPV vaccine to prevent cervical cancer. The respondents 
perceived that cervical cancer is a serious disease and that it was a threat to their 
daughters’ good health. These perceptions influenced the respondents’ behaviour  to 
accept the HPV vaccine (or to take their daughters for vaccination) so as to reduce the 
threat of cervical cancer .The respondents’ attitudes towards the HPV vaccine made it 
easy for them to vaccinate their daughters, thus protecting their health. 
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Almost all the studies discussed in the literature review showed that the respondents 
were in favour of HPV vaccine and that the vaccine was highly accepted. This was 
evidenced by the respondents’ willingness to vaccinate their daughters. This indicates a 
positive relationship between attitude and knowledge. 
 
To evaluate the relationship between education and attitudes, the p-value/significance 
was observed, such that if it is below 0.1 the conclusion is that there is relationship.   
 
The relationship between education and attitude was demonstrated by a significance of 
0.074 to the question ‘HPV vaccine is effective in preventing cervical cancer’. Further 
significance was observed in the questions ‘the girl should get all three doses of HPV 
vaccine’ and ‘it is important to complete all three doses’. The ANOVA test revealed that 
the respondents’ educational level had an influence on their answering these questions. 
For the rest of the questions, the respondents’ educational level did not seem to affect 
their attitude towards the vaccine. The respondents accepted the HPV vaccine the 
same way. 
 
Generally, there was a high level of awareness and knowledge of HPV/HPV vaccine 
which resulted in a positive attitude. This shows that respondents’ knowledge influenced 
their attitude thereby demonstrating an association between knowledge and attitude.  
 
Of the respondents, 81.5% had a positive attitude towards the HPV vaccine. A positive 
attitude implies a positive behaviour and compliance with the HPV vaccine. The results 
show that most of the respondents did not agree that the HPV vaccine causes infertility, 
which shows a lack of knowledge. This, in turn, shows that the adverse effects were not 
explained and supports the 38% who disagreed and 2% who strongly disagreed that the 
HPV vaccine information was not clearly explained.  
 
5.3.5 Behaviour towards HPV vaccine 
 
The third objective was to determine the respondents’ behaviour towards the HPV 
vaccine and HPV uptake. The objective was achieved as shown by respondents’ 
behaviour and utilisation of the prevention strategy. Of the respondents, 53% had 
immunised their daughters; 21% had completed their dosages, and 99% would 
encourage other parents to take their daughters for vaccination. Respondents with less 
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HPV infection knowledge still had a positive behaviour towards the HPV vaccine and 
were willing to vaccinate their daughters.  
 
Some respondents had vaccinated their daughters, and finished the doses. Those who 
did not vaccinate their daughters and those who did not receive all the doses expressed 
willingness to have their daughters complete or take the vaccine. Of the respondents, 
98% had nothing hindering them from vaccinating their daughters, which is a positive 
behaviour. There was a significant relationship between respondents’ behaviour and 
attitudes as evidenced by their intention to vaccinate their daughters and having their 
daughters vaccinated. The ANOVA showed no relationship between educational level 
and behaviour. All the respondents responded the same and showed the same 
behaviour.  
 
The results generally showed that the respondents’ behaviour towards the HPV vaccine 
was positive. The respondents’ positive attitude resulted in positive behaviour. Both 
males and females showed positive behaviour. The positive behaviour towards the HPV 
vaccine implies that the preventive strategy is or will be utilised effectively. 
 
This study has obtained similar results as other studies in the reviewed literature. 
Almost all the studies discussed reveal that respondents were in favour of HPV vaccine 
and showed a high acceptance of HPV vaccine. This was evidenced by the 
respondents’ willingness to vaccinate their daughters. This indicates a positive 
relationship between attitude and knowledge. 
 
5.4 COMPARISON BETWEEN MALE AND FEMALE RESPONDENTS  
 
A comparison was made to determine the relationship between the answers given in 
terms of knowledge, attitude and behaviour between male and female respondents. The 
null hypothesis is that there is no relationship between knowledge/attitude/behaviour 
and gender. This means that gender differences are not important in knowledge about 
HPV infection, cervical cancer and HPV vaccine. Males and females may be similarly 
knowledgeable.   
 
The first assessment was on the level of knowledge of males and females on HPV 
infection. The results show that most of the questions (5 out of 7) obtained a calculated 
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r-value higher than the tabled values. Question 2 calculated r-value is 2.816>0.7293; 
question 4 calculated r-value is 1.146>0.90000: question 6 calculated r-value is 2.098 
>0.90000; question 7 calculated r-value is 1.245>0.90000, and question 8 calculated r-
value is 1.555>0.90000. This rejects the hypothesis that there is a relationship. 
 
The second assessment was on knowledge on cervical cancer between males and 
females. The results showed that most of the questions (6 out of 11) obtained a 
calculated r-value below the tabled r-values. Question 10 calculated r-value is 
0.932<0.98769; question 12 calculated r-value is 0.576<0.98769; question 13 
calculated r-value is 0.285>0.98769; question 16 calculated r-value 0.489<0.90000; 
question 17 calculated r-value is 0.628<0.90000, and question 19 calculated r-value is 
0.403<0.90000. This means the null hypothesis of ‘no relationship between knowledge 
and gender’ is accepted. This is supported by males and females being knowledgeable 
or both answering the same way. In some questions males had the upper hand. 
 
Knowledge about the HPV vaccine was also assessed. The results showed that most of 
the questions (5 out of 7) obtained a calculated r-value above the tabled r-values. 
Question 22 calculated r-value is 4.630>0.7293; question 23 calculated r-value is 
1.838>0.90000; question 25 calculated r-value is 3.442>0.90000; question 26 
calculated r-value is 0.911>0.90000, and question 27 calculated r-value is 
3.146>0.90000. The above values reject the hypothesis that males are more 
knowledgeable than females. 
 
Attitudes towards the HPV vaccine were assessed between the males and females. The 
results showed that most of the questions (6 out of 11) obtained a calculated r-value 
below the tabled r-values. Question 5 was not included because it was relevant to 
females. Question 2 calculated r-value is 0.699<0.98769; question 3 calculated r-value 
is 0.240<0.90000; question 4 calculated r-value is 0.183<0.90000; question 7 calculated 
r-value is 0.515<0.8054; question 9 calculated r-value is 0.285<0.90000, and question 
10 calculated r-value is 0.684<0.90000.This accepts the hypothesis that there is no 
relationship between gender and attitude. 
 
Assessment was made on behaviour towards the HPV vaccine between males and 
females. The results showed that most of the questions (4 out of 5) obtained a 
calculated r-value higher than the tabled r-values. This rejects the hypothesis that there 
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is a relationship between behaviour and gender. Question 1 calculated r-value is 
1.449>0.900; question 2 calculated r-value is 0.819>0.8054; question 3 calculated r-
value is 1.273>0.98769, and question 4 calculated r-value is 3.581>0.98769. Although 
the statistics reject the hypothesis, the numbers (count) show that males and females 
answered the same way. 
 
All the wards were assessed on HPV infection, cervical cancer and HPV vaccine. The 
questions about the dosage intervals for HPV vaccine and the adverse effects of the 
vaccine were similar in all the wards. They all showed little knowledge on these 
questions. All the wards displayed little knowledge on the time period for doing Pap 
smears. The respondents in all the wards displayed positive attitude and behaviour 
towards HPV vaccine. 
 
5.5 CONCLUSIONS 
 
The study has found a positive relationship between attitude and behaviour and that 
attitude influences behaviour. Respondents’ positive attitude resulted positive 
behaviour. High awareness of cervical cancer and HPV vaccine had a great impact in 
the acceptance of HPV vaccine and positive behaviour towards HPV vaccine. This 
study found that the respondents believed cervical cancer is a serious disease and can 
cause death, and most of them knew someone who had cervical cancer. Furthermore 
the respondents believed that their daughters were vulnerable and at risk of contracting 
HPV infection and cervical cancer, therefore they showed positive behaviour towards 
the HPV vaccine as a way to prevent cervical cancer. The respondents voluntarily 
participated in the study and decided to allow their daughters to be vaccinated, thereby 
showing self-efficacy. Respondents felt confident about taking their daughters for 
vaccination. Messages or education from health workers and the media about the HPV 
vaccine led to positive behaviour as well since the majority of the respondents had 
heard about HPV/HPV vaccine.  In this study the respondents’ level of education did not 
seem to be a determining factor in their intention to vaccinate their daughters. 
Respondents with a lower level of education similarly had positive attitudes and good 
intentions.  
 
Most of the respondents were females who were aware and the ones affected by 
cervical cancer. The respondents had a positive attitude and behaviour towards the 
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HPV vaccine to avoid the threat of HPV and cervical cancer. There were no barriers to 
getting HPV vaccine since it is provided in primary schools by school health nurses at 
no cost. Almost all the respondents did not have any cultural or religious beliefs that 
hindered their daughters from receiving the HPV vaccine. 
 
From the results it can be concluded that the respondents had a medium to high 
awareness and knowledge about HPV infection, cervical cancer, and the HPV vaccine. 
HPV vaccine received a high acceptance rate which indicates a positive attitude. 
Positive behaviour was displayed by the number of girls vaccinated as well as the 
respondents’ willingness to have their daughters vaccinated and complete the three 
doses.  
 
5.6 CONTRIBUTION OF THE STUDY 
 
The findings from this study will contribute to the body of knowledge on HPV and the 
HPV vaccine, particularly in Botswana. Parents should be aware and knowledgeable 
about HPV and the HPV vaccine thereby contributing to reducing the incidence of HPV 
infections and cervical cancer.  
 
The study should raise awareness of early cervical cancer screening thereby reducing 
the health bill for the country. The findings should help in identifying areas that need 
emphasis in preventing cervical cancer by addressing areas that need improvement. 
This, in turn, should lead to improved effectiveness and implementation of the 
programme and improved immunisation coverage. Unimmunised girls who are eligible 
for immunisation will be identified and assisted accordingly.  
 
The study revealed the importance of explaining the dosage and intervals for the HPV 
vaccination. When parents and communities know the dosages and intervals, they will 
ensure that their daughters complete the doses and know when they are due for the 
next vaccination. In addition, parents will then know the likely adverse effects to expect. 
The study also revealed the importance of knowing the interval for Pap smears. The 
respondents stated that they found the study informative and educative. 
 
  
  
65 
5.7 LIMITATIONS 
 
This study was limited by financial constraints as it was self-sponsored, which affected 
obtaining the necessary materials and moving around the area, and prevented hiring 
field workers. In addition, most males were not willing to participate in the study as they 
believed it was for women since cervical cancer affects females. This resulted in a lower 
number of male respondents. 
 
5.8 RECOMMENDATIONS 
 
Based on the findings, the researcher makes the following recommendations for 
practice and further research. 
 
5.8.1 Practice 
 
The study found that many of the respondents did not know the dosage intervals for the 
HPV vaccine, and the adverse effects of the HPV vaccine. Many respondents also did 
not know how often Pap smears are done. This indicates a need for healthcare 
professionals to explain the information clearly. Health workers need to work hard in 
educating the community about the HPV, the HPV vaccine, cervical cancer and the Pap 
smear. Health talks/education should be emphasised so that parents can make 
informed decisions.  
 
5.8.2 Further research  
 
Further research should be conducted on the following topics: 
 
 An assessment of the uptake of the HPV vaccine and implementation of the 
prevention strategy. 
 The progression of HPV infection to cervical lesion or clearance. 
 Adolescents’ awareness, knowledge and perceptions of HPV and the HPV 
vaccine in urban and rural areas of Botswana. 
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5.9 CONCLUDING REMARKS 
 
Botswana has a high incidence of HPV infections and cervical cancer. The high 
prevalence of HPV contributes to increased morbidity and mortality of cervical cancer. 
The magnitude of cervical cancer in Botswana was of grave concern to the researcher. 
The HPV vaccine was licensed in Botswana in 2009, and is now given free to 
adolescent girls aged 9 to 13 years as a preventive strategy against HPV. Parents’ 
decision to vaccinate their daughters plays a crucial role in the successful 
implementation of the prevention programme. The public health benefit of the 
prophylactic vaccination can be achieved if parents have knowledge and positive 
attitudes towards the HPV vaccine.  
 
The study was a journey of discovery for the researcher who was encouraged by the 
respondents’ willingness and sharing.  
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ANNEXURE D 
Questionnaire 
 
Knowledge, attitudes and behaviour towards HPV and HPV vaccine among parents with 
adolescent 9-13 years girls in Sefhare, Botswana. 
 
Section 1: Demographic data                    Ward:                       Age of child: 
Question 
No 
Question Response  Code 
1 Gender  1. Male 
2. Female 
 
2 Age 1. 25-29 years  
2. 30-34 years  
3. 35-39 years  
4. 40-44 years 
5. 45 and above  
 
3 Level of Education 1. Never been to school  
2. Primary  
3. Secondary   
4. Tertiary  
 
4 Occupation 1. Unemployed  
2. Self employed  
3. Employed 
 
5 Marital Status 1. Single  
2. Married  
3. Divorced  
4. Widowed 
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Section 2: Knowledge Questions 
 
Question 
No 
Knowledge about HPV 
infection 
Response Code 
1 Have you ever heard about HPV 
infection? 
1. Yes 
2. No 
 
2 I heard about HPV infection 
from 
1. Friend 
2. Health worker  
3. Media 
4. Other (Specify)…………… 
 
3 Can HPV infection be 
transmitted through sex? 
1. Yes 
2. No 
3. No idea 
 
4 Does HPV infection cause 
cervical cancer? 
1. Yes 
2. No 
3. No idea 
 
5 Does using a condom partially 
protect one from contacting HPV 
infection? 
1. Yes 
2. No 
3. No idea 
 
6 Anyone who has had sex could 
contract HPV infection?  
1. Yes 
2. No 
3. No idea 
 
7 Can HPV infection be 
prevented? 
1. Yes 
2. No 
3. No idea 
 
8 Do multiple sex partners 
increase the risk acquiring HPV 
infection? 
1. Yes 
2. No 
3. No idea 
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9 Knowledge about cervical 
cancer 
 
  
10 Have you ever heard about 
cervical cancer? 
1. Yes 
2. No 
 
11 I heard about cervical from 1. Friend  
2. Health worker  
3. Media 
4. Other (Specify)………. 
 
12 Is cervical cancer a serious 
disease? 
1. Yes 
2. No 
3. No idea 
 
13 Cervical cancer can cause 
death 
1.Yes 
2.No 
3 No idea 
 
14 Cervical cancer is caused by 
HPV 
1. Yes 
2. No 
3. No idea 
 
15 Cervical cancer can be 
prevented 
1. Yes 
2. 2.No 
3. No idea 
 
16 Pap smear is used to detect 
cervical cancer 
1. Yes 
2. 2.No 
3. No idea 
 
17 Pap smear is done every 2-3 
years 
1. Yes 
2. No 
3. No idea  
 
18 Cervical cancer be treated if 
diagnosed early 
1. Yes 
2. No 
3. No idea 
 
19 Can cervical cancer affect the 
relationship between the 
husband and partner 
1. Yes 
2. No 
3. No idea 
 
20 Do you know anyone that 
has/had cervical cancer? 
1. Yes 
2. No 
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 Knowledge about HPV 
vaccine 
  
21 Have you heard about HPV 
vaccine? 
1. Yes 
2. No 
 
22 I heard about HPV vaccine from 1. Friend  
2. Health worker  
3. Media 
4. Other (Specify)………. 
 
 
23 HPV vaccine is used to prevent 
cervical cancer 
1. Yes 
2. No 
3. No idea/ N/A 
 
24 Do you know the dosage 
intervals of the vaccine? 
1.Yes 
2. No 
3. N/A 
 
25 Have you been told about the 
benefits of a girl being 
vaccinated? 
1. Yes 
2. No 
3. N/A 
 
26 Have the adverse effects been 
explained to you? 
1. Yes 
2. No 
3 N/A 
 
27 Do you know that the 
government offers HPV vaccine 
for free?  
1. Yes 
2. No 
3. N/A 
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Section 3: Attitude Questions 
Question 
No 
Questions Response Code 
1 I am able to make decisions that 
affect my household 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
2 I feel confident taking my 
daughter for HPV vaccination 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
3 There are health benefits for 
getting HPV vaccine 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
4 HPV vaccine is effective in 
preventing cervical cancer 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
5 I have no problem telling my 
child if I have cervical cancer 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
6 HPV vaccine prevents HPV and 
STIs 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
7 HPV vaccine can cause 
infertility 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
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8 It is best to administer HPV 
vaccine before sexual initiation
  
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
9 The girl should get 3 doses of 
HPV vaccine  
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
10 It is important to complete all 
the 3 doses 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
11 HPV vaccine information was 
clearly explained 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
 
12 HPV vaccine information was 
clearly publicised 
1. Strongly disagree 
2. Disagree 
3. Agree 
4. Strongly Agree 
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Section 4: Behaviour 
 
Question 
No 
Question Response Code 
1 Is your child immunised or 
vaccinated or vaccination? 
1. Yes 
2. No 
 
2 Did she complete all her 
dosages?  
1.Yes 
2.No 
3.N/A 
 
3 Do you have plans to immunise 
your child? 
1. Yes 
2. No 
3. N/A 
 
4 Would you encourage other 
parents to take their daughters for 
vaccination? 
1. Yes 
2. No 
 
5 Are there any girls that you know 
that are not immunised but are of 
age? 
1. Yes 
2. No 
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ANNEXURE E 
Consent form 
 
Good morning/afternoon sir/madam. My name is Kgola Senatla, a Master of Public 
Health student at the University of South Africa. As an academic requirement, I am 
doing research on the topic: Knowledge, attitudes and behaviour among parents 
with adolescent girls (ages 9-13) towards HPV and HPV vaccine. The purpose of 
the study is to determine or asses level of knowledge, attitudes and behaviour of 
parents towards HPV and HPV vaccine in preventing cervical cancer and HPV vaccine 
uptake. 
 
I have been given the permission to carry this study by the Ministry of Health and 
UNISA Higher Degrees Committee.  
 
Your name is not going to be written down, the information that you give me will not be 
associated with you anyhow. The information taken from you is going to be known to 
me and is not going to be shared with anyone or published. You are free at any time of 
the study to stop me and ask questions, and you are free to quit the study anytime you 
feel and there is no judgment against you. 
 
Although your participation in the study will help me with my studies, there are benefits 
to the community as well. This includes identifying knowledge gaps and those areas 
that need improvement, assess immunization access and coverage and evaluate the 
prevention and implementation strategy. The girls who did not get the vaccine but 
qualify to be given would be identified and helped accordingly. 
 
You are not compelled to take part in this research. 
 
If you agree to take part in this study, I am going to ask you a couple of questions. Do 
you want to participate? 
 
Signature of the respondent: ……………………. Date: ……………….. 
 
Researcher’s signature ………………………      Date: ……………. 
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